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Primary data collection for the original research project ‘Exploring the Experiences of 
People with Psychosis and Type 2 Diabetes (EXPAND)’ was adversely affected by the 
COVID-19 pandemic.  This subsequently led to the researcher abandoning their original 
project due to suspension in recruitment set out by NHS Research & Development. The 
following systematic review and secondary data study therefore represents a new research 
topic.  Some of the accompanying appendices refer to the original research topic and are 
titled accordingly.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 7 
Chapter 1     Systematic Review 
 
 
First episode psychosis and disengagement from early 
intervention services: An updated systematic review 
 
Chapter word count: 6,589  (including tables, figures, references) 
 
Prepared in accordance with Early Intervention in Psychiatry (see appendix 
1:1 
 
  
 - 8 - 
 
Abstract 
Aim 
This review offers an up to date examination of rates and predictors of engagement and 
disengagement amongst individuals with first episode psychosis using specialist early 
intervention services.  
Methods 
Three databases (Medline, PSYCHINFO and CINAHL) were systematically searched. 
Studies that examined engagement or disengagement from early intervention services for 
first episode psychosis, and published from 2012 and onwards, were included in the study. 
Nine papers were identified. The CASP Cohort Study Checklist was used to critically 
appraise methodological quality of included papers.  
Results 
Disengagement rates varied from 11.7% to 56.3% (Mdn=13%). Only two papers used 
validated tools to measure engagement. Poor medication compliance and substance abuse 
emerged as more robust predictors of disengagement. Inconsistent findings were found for 
clinical variables. Methodological differences across studies made comparisons between 
studies difficult. 
Conclusions 
In this up-to-date review of definitions and predictors of engagement in first episode 
psychosis, there still lacks consensus regarding a goal standard definition and measurement 
of engagement. There is a need for clearly defined measurement of service engagement and 
disengagement.  
Keywords 
Early intervention, engagement, disengagement, systematic review, First episode psychosis 
 - 9 - 
Word Count: 181 
  
 - 10 - 
 
Introduction  
First episode psychosis (FEP) can be a particularly distressing experience for individuals 
and those close to them. The onset of psychosis typically occurs during late adolescence and 
young adulthood during a time when individuals are transitioning into adult independence 
and embarking on new social and vocational opportunities. Experiences of psychosis are 
unique to the individual but can include experiences such as hallucinations, delusional 
beliefs, cognitive and interpersonal difficulties and changes in mood. Psychosis can result 
from a complex interaction of biological, psychological and the social aspects of human 
experience with much recent research highlighting the role of stressful life events and trauma 
(BPS, 2015). In particular, adverse childhood experiences greatly increases the likelihood of 
later expression of psychosis (Lataster et al., 2012). Rates of psychosis are also significantly 
higher in people from black and minority ethnic (BAME) backgrounds in the UK (Fearon et 
al., 2006) and their experiences of services can be poor (Boydell et al., 2012). The experience 
of overt and institutional racism can increase the rates of a host of mental health problems, 
including psychosis, and complex patterns of discrimination can make it less likely for 
BAME populations to seek help (Nicholls et al., 2007). Early intervention (EI) services for 
FEP were developed from the evidence that early intervention can have significant impact 
on the course of illness (Birchwood et al., 1998). EI services typically offer intensive case 
management delivered by a multidisciplinary team with a strong focus on developing 
therapeutic alliance to increase the likelihood of service engagement. The main goals of EI 
services are often to achieve symptom reduction, social recovery and relapse prevention.  
The effectiveness of any clinical intervention is dependent on the patient’s willingness 
to engage meaningfully with treatment. Disengagement in mental health services is an 
ongoing challenge, with reported rates of up to 50% higher than that of any other medical 
services (Mitchell et al., 2007). Definitions of disengagement can vary from refusal to 
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participate in a mental health intervention, to attending appointments but not taking part in 
session content (Tindall et al., 2018). Heterogeneity of definitions across studies can make 
comparisons difficult. Despite these methodological challenges, young adults experiencing 
first episode psychosis (FEP) have been identified as being a particularly challenging 
population group to engage (Dixon et al., 2016) with reported delays in accessing treatment 
of 1-3 years, and high attrition rates of up to 80% within the first year of entry to general 
mental health services (Kane et al., 2012). Early drop out from such services is associated 
with slower recovery, increased need for hospitalisation, higher levels of functional 
impairment (Dixon et al., 2016) and increased relapse (Stowkowy et el., 2012). 
Disengagement in this population group is therefore of particular concern.  
Engagement is a multi-faceted phenomenon and can change in response to various 
factors including stage of treatment, patients’ attitudes towards recovery, and changes in life 
and social circumstances (Lal & Malla, 2015). Specialised early intervention services for 
FEP have a specific emphasis on service engagement and multidisciplinary working to 
provide intensive biopsychosocial interventions to help reduce the duration of untreated 
psychosis, improve psychiatric symptoms and psychological outcomes, promote social and 
vocational recovery and prevention of relapse (Birchwood, 2014). Such services are more 
successful in engaging young people in care and for longer compared to that of typical 
mental health services (Dixon et al., 2015; Kane et al., 2016). A vital part of the success of 
these services is the role of the therapeutic alliance (Kvgric et al., 2013; Melau et al., 2015) 
which has consistently be shown to be a reliable predictor of successful outcomes in therapy 
(Hovarth et al., 2011; Tindal et al., 2020) and found to be a prerequisite for service 
engagement and good psychiatric outcomes in the FEP population (Melau et al., 2015). 
However, meta-analyses of therapeutic alliance on outcomes in therapy report effect sizes 
of r=0.27 suggesting that although clearly an important and necessary factor to promote 
recovery outcomes, not a sufficient in itself (Del Re et al., 2012). 
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An understanding of the factors associated with engagement, including demographic 
and clinical predictors, is crucial improving engagement and in developing approaches to 
reduce the risk of disengagement. A systematic review published by Doyle and colleagues 
(2012) reported that disengagement rates in early intervention services for FEP varied from 
20.5% to 40% across ten studies with the most robust predictors for disengagement shown 
to be co-morbid substance abuse and lack of family support. Doyle and colleagues (2014) 
found a lack of reporting on the potential impact of ethnicity, culture and deprivation on 
disengagement. However, such factors are commonly associated with disengagement in the 
broader mental health literature (Lal & Malla, 2015). There was also found to be no accepted 
definition or measurement of engagement or disengagement across the studies. This was 
mirrored by a recent review by Reynolds and colleagues (2019) which looked at how 
disengagement in FEP from mental health services were defined, measured and 
operationalised across 30 published studies and found that very few studies considered 
similar factors in their definition. 
 The purpose of this review is to build upon the previous review by Doyle and 
colleagues (2014) and to examine the current rates of disengagement, and predictors of 
engagement and disengagement amongst individuals living with FEP using EI services. The 
aims of the current review are as follows: 
1. To provide an up to date account of the rates of disengagement in early 
intervention services 
2. To examine definitions of engagement and disengagement 
3. To identify predictors of engagement and disengagement. 
 
Methods 
Eligibility Criteria  
Participants  
 - 13 - 
Individuals with a first episode psychosis.  
 
Intervention/ Exposure 
Specialist early intervention service for first episode psychosis. 
 
Comparator / Context 
Studies were limited to early intervention services for first episode psychosis. Studies that 
were set in general mental health studies were excluded from the review. 
 
Outcome 
Rates and predictors of engagement and disengagement in EI services.   
 
Study Design 
Studies included cohort studies and those which were published from 2012 and onwards. 
Studies were excluded if they were not published in English, dissertations, conference 
abstracts, and book chapters. Qualitative research and studies which employed mixed 
methods were excluded from the review 
 
Search Strategy 
The databases Medline (2012-2020), PsychInfo (2012-2020) and CINAHL (2012-2020) 
were searched on the 18th May 2020 using the following search string:  (schizophrenia or 
psychosis or psychoses or psychotic disorder or schizophrenic disorder or schizoaffective 
disorder ) OR (first episode psychosis or early psychosis or early onset psychosis) AND 
(engagement or involvement or participation) or (disengagement or non-compliance) or 
(dropout or drop out or drop-out) AND (engagement predictors) OR (predict or predictors 
or predictive). The review looked to update results from a systematic review by Doyle and 
colleagues (2014) which searched papers published up to 2012. The current review therefore 
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searched for papers published from 2012 onwards. Title and abstract screenings were 
conducted on the search to decide upon which papers to exclude based on inclusion criteria. 
Papers which met criteria were then reviewed in full and independently assessed on its 
relevance to decide whether to include in the review. A manual search of the literature was 
also conducted in order to exhaust all possibilities and reduce bias. This included searching 
reference lists of included articles to identify any pertinent studies. Citation searching of 
included studies was then carried out and lastly, a manual search on Google scholar was 
conducted using key terms and searching prominent researchers in the field of first episode 
psychosis.  
 
Ratings of Methodological Quality 
The Critical Appraisal Skills Programme (CASP) quality tool for cohort studies was used to 
assess the quality of the studies included in the review (CASP, 2018). The tool consists of 
12 questions to assess components such as the purpose of the study, recruitment, risk of bias, 
accountability of cofounding factors, follow-up, levels of evidence, comparability and 
implications for practice. The tool does not act as a checklist or offer a scoring system but 
helps reviewers focus on key concepts for evaluating the validity of studies and was used in 
the current review to encourage critical consideration of studies and the area of engagement. 
Data were extracted from eligible full-texts and structured in an extraction excel sheet which 
classified patient characteristics, outcomes, and critical appraisal of the papers using the 
CASP. 
Results 
The search strategy yielded 328 articles following deduplication. Following screening of 
titles and abstracts, the final sample consisted of 9 articles that met eligibility criteria for 
inclusion in the review. Figure 1 shows a diagram of the searching process.  
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Figure 1: Flowchart of the study selection process and results for inclusion in the 
systematic review. 
 
Study Characteristics 
The combined sample was comprised of 3925 participants. Samples ranged from n=64 
(MacBeth et al., 2013) to n=786 (Solmi et al., 2018). Males made up 61.4% (n= 2410) of the 
sample. Publication dates were between 2013 (MacBeth et al., 2013; Zheng et al., 2013) to 
2019 (Kim et al., 2019; Lavelic et al., 2019).  Three studies were based in the UK, 2 based 
in Canada, 2 in Hong Kong, 1 in Singapore and 1 in Australia. In terms of methodology, five 
studies were prospective (Casey et al., 2016; Maraj et al., 2018; Ouelett-Plamondon et al., 
2015; Solmi et al., 2018; Zheng et al., 2013) three retrospective (Chan et al., 2014; Kim et 
al., 2019; Lau et al., 2017) and 1 cross-sectional (MacBeth et al., 2013). Study characteristics 
and main findings from studies can be found in table 1.  
 
Rates of Disengagement 
Seven studies reported rates of disengagement which ranged from 11.7% to 56.3% (Mdn = 
13%). The majority of studies reported rates of disengagement within the context of a two-
year follow up period, with the exception of Solmi et al., (2018) who reported rates of 
disengagement over a three-year period of care.  
Kim et al. (2019) reported the highest rates of disengagement with over half of an 
Australian cohort disengaging at least once over the course of treatment (56.3%). However, 
they found that the majority of individuals re-engaged (85.5%) with only a small percentage 
of participants never re-engaging after initial drop out. Solmi et al., (2018) reported the 
lowest rates of disengagement (11.7%) in a cohort in the East of England. These varying 
rates of disengagement should however be viewed in light of the wide variety of definitions 
used to capture disengagement.  
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Author & Year Setting N Mean 
Age 
Male 
N(%) 
Ethnicity Study Design Measurement / Definition of disengagement Relevant Findings 
Casey et al. 2016 Early Intervention 
Service 
 
Birmingham, UK 
103 23 
  
73 (71%) Asian 33% 
Black 25% 
White 36% 
Other 8% 
Prospective 
study over a 2 
year period 
Results of SOLES questionnaire. Higher score 
represent better engagement.  
Predictors of engagement 
Beliefs that mental illness is caused by social stress  (p=0.002) or 
thinking odd thoughts (p=0.008). Individuals with no qualifications 
have higher engagement scores that those educated at a higher level 
(p=0.0015).  Duration of untreated illness (DUI) significantly 
predicted higher engagement scores, but only for values > 1220 days 
Chan et al. 2014 Early Assessment 
Service for Young 
People with 
Psychosis 
Hong Kong  
700 20.65 
  
360 (51%) Not reported Retrospective 
historical case 
control design 
with two year 
follow-up 
Continuous default of out-patient appointments 
despite therapeutic need and active tracing from 
staff. 
No standardised tool of measurement used. 
Rate of disengagement  
13% within 2-year period 
Significant predictors of disengagement 
Fewer baseline negative symptoms (p=0.002), diagnosis other than 
schizophrenia spectrum disorder (p>0.001) and poor medication 
compliance in first three months (p<0.001). 
Kim et al. 2019 Early Psychosis 
Prevention and 
Intervention Centre 
(EPPIC) 
 
 
Melbourne, 
Australia 
700 19.5 
  
421 
(60.10) 
Not reported Retrospective 
case design 2 
years follow 
up 
 
Naturalistic 
cohort study 
Active refusal of any contact with the treatment 
facility or non-traceable.  
Engagement Rates 
56.3% disengaged at least once during treatment period; however, the 
majority (85.5%) subsequently re-engaged.  
Significant Predictors of disengagement 
NEET (p=<0.001), family history of psychosis in the 2nd degree 
(p=0.03), cannabis abuse (p=0.001) 
No significant predictors of re-engagement emerged. 
Lau et al. 2017 Early Assessment 
Service for Young 
People with 
Psychosis (EASY) 
 
 
Hong Kong 
277 Mean age 
not 
reported 
 
N = 122  
aged 15-
25 years; 
N = 155 
aged 26- 
64 years  
  
126 (45) Not reported Retrospective 
with 2 year 
follow-up  
Type I disengagement: defined as continuous 
default from the service. Type II: continuous 
default from service and re-engagement through 
hospitalisations. Type III: 2 or more consecutive 
defaults from the outpatient appointments and re-
engaged to the service. 
Rates of disengagement 
Type 1 = 13%, type II=4.3%, type III = 13.4% 
Predictors or disengagement 
Poor drug compliance predicted type I (p<0.01) type II  (p>0.01) and 
type III disengagement (p=0.01). History of substance abuse (p=0.03) 
and history of self harm/suicide (p=0.03) also predicted type III 
disengagement. Younger people had significant earlier 
disengagement (p=0.025). 
 
Younger people (aged 15-25) had significant earlier disengagement 
(x2=5.01, p=0.025) compared to those who were older (26-64). 
MacBeth et al. 2013 Early Intervention 
services for 
psychosis 
 
Scotland 
64 23.67 43(67%) White British 90.6% 
Other 6.4% 
Not reported 3.1% 
Cross-
sectional study    
Results of SES questionnaire. Lower scores 
indicate higher levels of engagement.  
Engagement and clinical Correlates 
Poor clinical engagement is associated with greater positive 
(r=0.388), negative (r=0.653) and greater general (rs=0.335) 
psychopathology and poorer premorbid social adjustment (r=0.426). 
 
Predictors of engagement 
Severity of negative symptoms significantly predicted engagement 
(p<0.001). 
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Maraj et al. 2018 Early Intervention 
for Psychosis 
Service 
 
Canada  
297 22.8 203 
(68.40) 
Caucasian 66% 
Black 12% 
Asian 8% 
Other 14% 
Prospective 
cohort study 
with 2-year 
follow-up 
No clinical contact for at least three consecutive 
months.  
Rate of disengagement 
24.2% with an average time of disengagement of 13.3 (SD=5.7) 
months.  
 
Predictors of disengagement 
Rates were similar between immigrants and non-immigrants but 
reasons for disengagement differed.  
Medication non-adherence predicted disengagement (p<0.05) in all 
groups. For first generation immigrants age was an additional 
predictor. For second generation immigrants, material deprivation 
was an additional predictor.  
Ouellet-Plamondon et 
al. 2015 
Early Intervention 
service for first 
episode psychosis 
Montreal, Canada 
223 22.97 
 
Range 18-
30 
274 (81.5) Country of origin 
Canada 58% 
USA 2% 
Europe 21% 
Africa 10% 
Carribean 24% 
Mexico, Central and South 
America 14% 
Middle Eastern and North 
Africa 15% 
Asia 8% 
Longitudinal 
prospective 
cohort study 
with 2 year 
follow up  
Participant refusal of follow-up or unreachable for 
more than three months 
Rates of disengagement 
6-18% 
Immigrants had three times the odds of attrition than non-immigrants 
for first generation (p=0.49) and second generation (p=0.039) 
immigrants.  
Solmi et al. 2018 Early Intervention 
Service for First 
Episode Psychosis 
 
 
East Anglia, UK 
786 Mean not 
reported. 
 
Range= 
16-35 
515 
(65.78) 
White British 77% 
White Other 12% 
Black 4% 
Other Black and Minority 
Ethnic 6% 
Bangledeshi/Pakistani 3% 
 Prospective 
study over 
three years 
Disengagement assumed to occur when all 
possible ways to engage were explored by clinical 
team.  
 
Time period disengagement said to occur was 
usually 6-8 attempts over a 2-3 month period. 
Rates of disengagement 
11.7% over three-year period 
Predictors of disengagement 
Participants who did not received FEP diagnosis, had. DUI of 
between 5 and 8 weeks, history of polysubstance misuse had a great 
risk of disengagement 
Those who were unemployed, more severe psychomotor poverty, and 
first-rank delusions were at lower risk of disengagement 
Zheng et al. 2013 Early Psychosis 
Intervention 
Programme (EPIP) 
 
Singapore 
775 Mean age 
not 
reported. 
 
Range 15-
40 
395 (51) Chinese 77% 
Malay 14% 
Indian 7% 
Other 2% 
Prospective 
study  
 
Two years 
follow-up  
 A semi structured scale measuring the amount 
and type of contact maintained between case 
managers and patients. Disengagement said to 
occur when patients drop out without clinical 
resolution, or moves out of catchment area or 
refuses services. 
Rates of disengagement 
14% over two years follow-up 
Predictors of disengagement 
Malay ethnicity (p<0.017) and lower level of education (p<0.009).  
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Measurement of Service Engagement 
Two studies investigated engagement using validated tools of measurement. MacBeth et al. 
(2013) used the Service Engagement Scale (SES; Tait et al., 2002) in which lower scores 
indicate better engagement, and Casey et al. (2016) used the Singh-O’Brien Level of 
Engagement Scales (SOLES; O’Brien et al., 2009) with higher scores indicating better 
engagement.  
Seven studies investigated disengagement (Chan et al., 2014; Kim et al., 2019; Lau 
et al., 2017; Maraj et al., 2018; Ouellet-Plamondon et al., 2015; Solmi et al., 2018 and Zheng 
et al., 2013). Of these studies, one developed their own semi-structured scale to measure the 
amount and type of contact maintained between case managers and patients. There was no 
agreed upon definition of disengagement. Definitions ranged from dropping out of treatment 
before completion of EI programme (Zheng et al., 2013) to having no clinical contact for 
three months (Maraj et al., 2018). Lau et al. (2017) defined three types of disengagement 
which included continuous default from the service, continuous default and re-engagement 
through hospitalisation, and continuous defaults from out-patients and subsequent re-
engagement. One study (Zheng et al., 2013) identified those who had moved out of the area 
as ‘disengaged’ whereas other studies explicitly stated this was not considered as 
disengagement (Solmi et al., 2018; Maraj et al., 2018).  
For studies that focussed on disengagement, there did not seem to be an agreed time 
frame in which disengagement was said to occur. Three studies reported disengagement 
occurred when no clinical contact was made within three months (Ouellet-Plamondon et al., 
2015; Maraj et al., 2018; Solmi et al., 2018) whilst others did not provide timeframes (Zheng 
et al., 2013).  
 Two studies reported on re-engagement of individuals who initially disengaged 
(Kim et al., 2019; Lau et al., 2017). In contrast, Zheng et al. (2013) considered those who 
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returned to treatment after dropping out as remaining in treatment. Therefore, those 
classified as disengaged in some studies, are classified as engaged in other studies. 
 
Predictors of Disengagement 
A summary of the findings related to predictors of engagement and disengagement can be 
found on table 2.  
 
Sociodemographic predictors 
All studies investigated sociodemographic predictors of engagement or disengagement and 
in general were consistent in their lack of findings.  From the seven studies that explored 
gender, one study found weak evidence suggesting men to be at higher risk of disengagement 
(Solmi et al., 2018).  
Lau et al. (2017) was the only study to find age as a significant variable and found 
that younger people aged 15 to 25 had significantly earlier disengagement compared to 
patients aged 26 to 64 years old. However, it should be noted that this sample was older than 
other samples in the review due to broader aged related entry criteria of the EI service under 
investigation. 
 Three studies explored the role of ethnicity. Two studies conducted in the UK (Solmi 
et al., 2019; Casey et al., 2016) did not find ethnicity to have a significant impact on level of 
engagement.  In contrast, Zheng and colleagues  (2013) found that Malay ethnicity, which 
represented 14% of the sample, was a significant predictor of disengagement amongst a 
cohort in Singapore.  
Two Canadian studies explored immigrant status on levels of engagement with 
mixed results. Ouellet-Plamondon et al. (2015) found that immigrants were three times more 
likely to disengage from treatment. In contrast, Maraj et al. (2018) found that immigration 
status was not predictive of disengagement; however, reasons for disengagement differed 
between immigrant and non-immigrant groups with medication adherence being predictive 
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in both groups, and the addition of age and material deprivation being predictive in first- and 
second-generation immigrants, respectively. This may suggest consideration of different 
approaches when formulating engagement amongst immigrant populations in FEP. 
 Three studies explored employment, education and training and mixed findings were 
found. Whilst Kim et al. (2019) found not being in employment, education or training was a 
significant predictor of disengagement. Zheng et al. (2013) found no association. 
Additionally, Solmi et al. (2018) found that those in employment at baseline were at higher 
risk of disengaging.  
Five studies investigated the impact of education on levels of engagement. Casey et 
al. (2016) found that individuals with no qualifications were found to have higher 
engagement scores than those educated to a higher level. Three studies found education was 
not predictive of disengagement (Chan et al., 2014; Lau et al., 2017; Maraj et al., 2018) 
whilst one study found individuals with less than six years of education were more likely to 
disengage (Zheng et al., 2013). 
The previous systematic review found lack of family involvement to be a robust 
predicator of disengagement (Doyle et al., 2014). Studies included in the current review were 
consistent in their lack of findings between lack of family involvement and disengagement. 
Two studies explored lack of family involvement (Maraj et al., 2018; Solmi et al., 2018) and 
found no associations with disengagement. Two studies investigated family contact  on rates 
of disengagement and found no significant results (Maraj et al., 2018; Solmi et al., 2018).   
Additionally, two other studies found living alone was not predictive of disengement (Lau 
et al., 2017; Zheng et al., 2013). 
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Clinical Predictors 
Six studies investigated the role of clinical predictors with two studies looking at 
predictors of engagement (Casey et al. 2016; MacBeth et al., 2013) and four investigating 
their role in disengagement (Chan et al., 2014; Lau et al., 2017; Solmi et al., 2018; Zheng et 
al., 2013).  Results of these studies were mixed. There was some evidence that lower 
symptom severity was associated with greater disengagement. Two studies (Solmi et al., 
2018; Chan et al., 2014) found that patients who had fewer negative symptoms at baseline 
were more likely to disengage. In contrast, Macbeth et al. (2013) found severity of negative 
symptoms was predictive of poorer engagement. Other studies found no significant impact 
of negative symptoms on disengagement (Lau et al., 2017; Zheng et al., 2013).  Severity of 
positive symptoms were not found to be predictive of disengagement (Chan et al., 2015; Lau 
et al., 2017) or engagement (MacBeth et al., 2013). People with more severe hallucinations 
were found to be at a higher risk of disengagement in one study (Solmi et al., 2018) 
 
Substance Use 
Five studies investigated the role of substance abuse on disengagement. Polysubstance abuse 
(Solmi et al., 2018), history of substance abuse (Lau et al., 2017) and cannabis use (Kim et 
al., 2019) were found to be significant predictors of disengagement. Chan et al., (2014) 
reported substance abuse history within the first six months of contact with EI service 
predicted disengagement in a cohort in Hong Kong but such results should be interpreted 
with caution due to low rates of substance abuse in their cohort compared to Western 
countries. Maraj et al. (2018) found no association between substance use and 
disengagement.  
 
Diagnosis 
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Five studies included in the review investigated the role of diagnosis (Casey et al., 2016; 
Chan et al., 2014, Lau et al., 2017; Kim et al., 2019, Solmi et al., 2018). Two studies found 
diagnosis was predictive of disengagement (Chan et al., 2014; Solmi et al., 2018). A 
diagnosis other than schizophrenia spectrum disorder including; affective disorders with 
psychotic features, acute and transient psychosis, and unspecified non-organic psychosis, 
were associated with a two-fold increased risk of disengagement (Chan et al., 2014). There 
was also evidence that individuals using an EI service who were later found to not meet 
diagnostic criteria for FEP were significantly more likely to disengage.  
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Table 1 Studies that reported predictors of engagement or disengagement 
           
  
Casey et al 
(2018)* 
Chan 
et al 
2014** 
Kim et 
al 
(2019)
** 
Lau et 
al., 
(2017)** 
MacBeth 
et al., 
(2013)* 
Maraj et 
al., 2018) 
** 
Ouellet-
Plamondon 
(2015)** 
Solmi 
et al., 
2018** 
Zheng 
et al., 
2013** 
Sociodemographic 
                  
  
Age or age of onset N N N Y 
 N  N N 
Gender N N N N N N 
 Y  
Race / Ethnicity N 
      N Y 
Immigrant Status 
     N Y   
First Language 
         
Living Status N 
        
Living alone or without family 
   N     N 
Family Contact  
     N  N  
Marital Status N 
  N     N 
Employment 
       Y**  
Unemployed/not in 
education/not in training 
  Y      N 
Educational level Y N 
 N  N   Y 
Social Deprivation Index 
     N    
Material Deprivation Index  
     N    
SES N 
        
Clinical    
         
  DUP N 
       Y 
  DUI Y 
      Y**  
  Length of prodrome N 
        
  CGI-SCH Positive 
 N  N      
  CGI-SCH negative 
 Y  N      
  Psychomotor povery 
       Y*  
  First-rank delusions 
       Y*  
  
Greater Hallucinations 
symptoms 
       Y**  
  Prodrome N 
        
  SOFAS 
 N        
  PANSS total score 
         
  PANSS negative 
    Y    N 
  PANSS positive 
    N     
  
PANSS general 
psychopathology 
    N    N 
  PANSS insight  
        N 
  Severity of manic symptoms 
       Y*  
Medication    
         
  
Poor medication compliance 
 Y  Y  Y    
Taking SGAs 
 N        
Not Taking SGAs 
         
  History of substance abuse 
         
Premorbid   
          
  Forensic history 
   N       
  Family history of psychosis 
       N   
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  1st degree relative 
  N        
  2nd degree relative 
  Y        
  
Academic premorbid 
adjustment 
    N      
  Social premorbid adjustment 
    N      
  
History of self harm or suicide 
attempt 
   Y       
Substance Use   
          
  Any substance abuse 
 N  Y  N  Y**   
  Cannabis abuse 
  Y        
 Amphetamine use   N       
Psychological    
          
  Symptom attributions N 
         
  
  
  Beliefs about mental illness 
Y          
 
 
          
Diagnosis  Schizophrenia spectrum 
 N  N       
 
Affective Psychosis 
  N        
 
Non-Affective Psychosis 
  N        
 
Substand Induced Psychosis 
          
 Diagnosis other than schizo-
affective  
 Y         
 Other psychosis    N      
 
No FEP 
       Y**   
 
Diagnostic groups N 
         
*denotes predictors of engagement  **denotes predictors of disengagement 
SES: socio-economic status; DUP: duration of untreated psychosis; DUI: duration of untreated illness; CGI SCH: Clinical Global Impression – Schizophrenia scale; 
SOFAS: the Social and Occupational Functioning Scale; PANSS: the Positive and Negative Symptom Scale; QOL: Quality of Life; GAF:Global Assessment of 
Functioning; FEP: first episode psychosis 
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Quality of Studies  
Critical appraisal showed that sampling bias was prominent across studies. In 
general, females were under-represented across studies accounting for 38.6% of the overall 
sample. Casey et al. (2016) and Ouellet-Plamondon et al. (2015) had a particularly high 
percentage of males in their sample, 71% and 81.5% respectively.  Zheng et al. (2013) had 
particularly high sampling bias by excluding those who had a history of substance abuse and 
forensic history despite these being evidenced as robust predictor of disengagement (Doyle 
et al., 2014). They also included those who had moved out of the area in their definition of 
disengagement, a factor which most other studies explicitly stated was not included in their 
definition of disengagement (Solmi et al., 2018; Maraj et al., 2018).  
Heterogeneity in definitions and measurement of engagement is also a cause of 
concern with only two studies using validated measures of engagement (Casey et al., 2016; 
MacBeth et al., 2013). A lack of consensus regarding the definition of engagement and 
disengagement means the definition used in individual studies are unlikely to reflect all 
relevant aspects of the phenomena. Is it important to consider definition and criteria used for 
disengagement in individual studies before considering results in the context of local 
populations.  
Studies with employed historical case control methodology (Chan et al., 2014; Kim 
et al., 2019; Lau et al., 2017) were prone to classification bias with methodological 
constraints meaning predictor variables under investigation were restricted to information 
available in clinical records. Additionally, confounders were a concern in some retrospective 
studies which were unable to assess for the contribution of previously evidenced variables 
on disengagement, such as lack of family involvement. Some studies were clear in which 
actions were taken to try and reduce classification bias (Chan et al., 2014; Kim et al., 2019) 
whilst others were not (Outlett-Plamondon et al., 2015). To control for bias in the collection 
of routine date, Chan et al., (2014) held weekly consensus meetings to ensure data and 
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reported ICC scores between clinicians and researchers which demonstrated satisfactory 
validity and reliability and other studies used advanced statistical methods to help control 
for the potential effects of confounders (Casey et al., 2016; Kim et al; 2019).  
Longitudinal designs (Casey et al., 2016; Maraj et al., 2018; Ouellet-Plamondon et 
al., 2015; Zheng et al., 2013 Solmi et al., 2018) benefited from follow-up period spanning 
the length of the EI programme which varied from 24 to 36-month follow-up.  MacBeth et 
al., (2013) was the only study in the review which used cross-sectional methodology, and 
had a smaller sample size (n=64) with subsequent limited statistical analyses and thus results 
from this study should be interpreted with some caution.  
 
Discussion 
 
This review offers an up to date review of engagement of individuals with FEP using an EI 
services. Similar to findings of a past systematic review (Doyle et al., 2014) no progress has 
been made with respect to developing consensus on the definition and measurement of 
engagement or disengagement. Current methods tend to use measures such as treatment 
adherence, therapeutic alliance and attendance; however, there are clear inconsistencies in 
how these are defined. Validated tools such as the SES (Tait et al., 2002) and SOLES 
(O’Brien et al., 2009) can be useful; however, these are clinician rated and there are a lack 
of measures that explicitly rate service users’ perspectives on engagement or the quality of 
engagement. Lal & Malla (2015) have commented on engagement in EI services as a non-
linear process and argued for the need of services to respond to patients in relation to stages 
of treatment, individual needs and developmental factors. Qualitative research has also 
highlighted the varying patterns of disengagement in EI services and disengagement being 
the product of inadequate support given by non-flexible mental health services (Tindall et 
al., 2020). Future research should focus on experiences from individuals with FEP and their 
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families to help inform patient-orientated definitions of engagement and reduce the current 
bias associated with clinical rated tools and service led definitions of engagement.  
In terms of predictors of engagement and disengagement, only lack of medication 
adherence emerged as a strong predictor. This finding is perhaps unsurprising given that lack 
of medication adherence is likely indicative of poor treatment engagement in general. 
However, reasons behind poor medication compliance and subsequent disengagement are 
complex. It has been postulated that individuals may perceive treatment as being focussed 
around medication in EI services and once they have stopped complying with medication, 
other treatments are felt unnecessary (Maraj et al., 2018). Beliefs around medication can also 
affect medication compliance. In a qualitative study of patients with schizophrenia, external 
factors and coercive measures were found to influence use of medication and early non-
adherence was explained by stigma related to medication use and lack of belief in illness 
models communicated by service providers (Tranulis et al., 2011).  Exploration of service 
users’ beliefs around medication and shared decision is therefore an essential step in 
supporting individuals with FEP using EI services.  
The review found that in general sociodemographic variables were not predictive of 
disengagement. Ethnicity was however found to be significant predictor of disengagement 
amongst a Hong Kong cohort (Zheng et al., 2013). This was theorised to be the result of 
specific ethnic, cultural and religious differences between Malay and Chinese populations 
with possible higher tolerance of mental illness and different health beliefs seen amongst 
Malay families, subsequently impacting upon engagement. However, the lack of research 
investigating the role of ethnicity and culture makes comparison difficult.  Anderson et al., 
(2014) found ethnicity was associated with differences in help seeking behaviours and 
models of illness in FEP, and non-European immigrants have been found to underuse mental 
health services (Whitley et al., 2006). Further research is warranted to increase our 
understanding of ethnic and cultural factors in FEP populations.  
 - 29 - 
 Inconsistent findings were found regarding the impact of clinical factors on 
engagement and disengagement. Interestingly, there was some evidence for higher symptom 
severity and better engagement (Solmi et al., 2019; Chan et al., 2014) and hypothesised that 
such individuals could be more motivated to engage or are encouraged to engage by family 
and clinicians to help ensure compliance to treatment.   
Over half the studies in the review investigated the role of diagnosis on levels of 
engagement. Interestingly, one study found those with a diagnosis other than schizophrenia 
spectrum disorder were more likely to disengage and was hypothesised this was due to better 
earlier outcomes. Longitudinal qualitative research using an Australian FEP cohort has 
criticised EI services for being diagnostically led and called for services to shift away from 
diagnostic labels and focus on individuals need due the evolving nature of psychotic 
symptoms and uncertainty regarding eventual diagnosis (Tindall et al., 2020). Lack of 
diagnostic ‘fit’ in EI services has been identified as a contributing factor for both service 
user and clinician in disengaging from the therapeutic relationship, despite there being a 
clinical need for support. However, people who later turn out not to fit criteria for psychotic 
disorder may quite appropriately be disengaging from services that are unsuitable for their 
needs.  
 
 
Strengths and Limitations 
The ability to draw conclusions is inherently restricted by the quality of studies included in 
the review. The review benefitted from the majority of the studies using prospective 
methodology and the overall sample represented a natural cohort of individuals with first 
episode psychosis. The review had some notable limitations. Firstly the heterogeneity of the 
studies in terms definition and measurement of engagement made it difficult to meaningfully 
compare studies. Methodological differences also presented as a challenge with some studies 
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using case files and others having smaller sample sizes which raises questions of validity 
amongst some studies. The use of validated tools helps to focus engagement as a process 
compared to those that use ‘disengagement’ as an outcome. Unfortunately, only two studies 
used a validated tool. The current review also excluded qualitative studies and thus the 
perspective of service users and their families are missing. None of the reviews explored 
aspects of the therapeutic relationships on engagement which has been highlighted in 
qualitative literature as being fundamental for the success of EI services from the service 
users’ perspective. (Tindall et al., 2018).   
Although the CASP tool for cohort studies was used to appraise the papers included 
in the review, the tool offers no summary scores to produce an overall rating for the papers. 
However, Crowe and Sheppard (2011) have previously criticized summary scores in critical 
appraisal tools for potentially ignoring significant weaknesses in one area due to higher 
scores in other areas and the use of weighting schemes has been suggested to increase 
emphasis on more important aspects of the research. As no summary scores were produced, 
quality reviews of papers were not assessed for inter-rater reliability which could present as 
a possible limitation.  
 
Implications for Research  
There still does not exist an agreed upon definition for service engagement and 
disengagement. It is only when a consensus is reached that we will be able to meaningfully 
compare studies and identify robust contributing factors to engagement. Current measures 
of engagement are narrow in their focus in only representing engagement from the clinicians’ 
perspectives. Working alongside individuals with FEP and their families is essential in order 
to develop tools for service engagement which represent the different stakeholders involved. 
Past research has commented on times during EI treatment which may be more sensitive to 
disengagement such as in the early stages and towards the end of treatment (Conus et al., 
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2010). This is an important consideration in future research if we are to understand the mutli-
faceted nature of engagement.  Only few studies in the current review commented on re-
engagement after initial drop-out which helps to highlight engagement as a non-linear 
process. Further research on reasons why individuals re-engage is an important next step in 
understanding the engagement and enhancing potential for recovery. Finally, engagement is 
multi-faceted and it is likely that many complex factors are at play when an individual is at 
risk of poorer engagement. Consideration of the interplay of complex service, system and 
cultural factors on service engagement warrants further attention (Lal & Malla, 2015).  
 
Implications for practice 
The evidence reviewed suggested that disengagement in EI services varied between 11.7% 
and 56.3% amongst individuals with FEP. These rates are much more variable than 
previously suggested (Doyle et al., 2014) and likely a result of heterogeneity in definitions 
and measurement of engagement. The current review highlighted medication non-adherence 
as one of the most robust predictors of disengagement. Services should invest in discussion 
surrounding service users health beliefs regarding medication and treatment in general, to 
help enhance service engagement.  Reports of contradictory findings of predictors of 
engagement and disengagement call for qualitative research for disengagement and also 
highlight that each experiences of engagement in EI services is likely unique to the 
individual. This suggests the need for tailoring support to the particular needs of the person 
and working with individuals and their families to develop a shared formulation with 
consideration of their ethnicity, culture and specific life experiences, which should also takes 
into account how the person with psychosis views their difficulties. Those studies which 
looked at the impact of ethnicity on engagement highlighted the need for services to consider 
different cultural frameworks. People from ethnic and other minority backgrounds may find 
it difficult or challenging finding therapists who share similar cultural frameworks for 
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understanding mental illness and psychosis. It is important that such frameworks are 
represented, or at the very least understood, in EI services.  
 
 
Conclusions 
Service engagement and disengagement is a complex phenomenon which we are yet to fully 
understand with challenges in measuring and defining the phenomenon making it difficult 
to compare findings across studies and research investigating predictors of disengagement 
are inconsistent in their results. Previous systematic review highlighted lack of family 
involvement and substance abuse as robust predictors. Our findings are consistent with 
research which indicates substance abuse as robust predictor however evidence for family 
involvement was lacking.  
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Plain English Summary  
Title 
Service Engagement in First Episode Psychosis: A Prospective Study 
 
Background 
Engagement in early intervention services is crucial for improving the clinical outcomes in 
people with first episode psychosis. It has been suggested that around 30% of young adults 
with first episode psychosis disengage from early intervention services. This is a cause for 
concern given that disengagement is associated with slower recovery, increased 
hospitalisation and increased risk of relapse. Our understanding of the factors that are 
associated with engagement is still poorly understood. Increasing our understanding of 
factors which predict engagement may help to target intervention to encourage better 
engagement in first episode psychosis and improve outcomes.  
 
Aims and Questions: 
To investigate predictors of engagement in first episode psychosis. The research questions 
include: 
1) What are the demographic and clinical characteristics of individuals with first 
episode psychosis at the point of acceptance to an early intervention service? 
2) What are the associations between engagement, service attachment and carers burden 
of care at 12-weeks following entry to the service? 
3) What are the baseline demographic, clinical and psychiatric factors that predict 
service engagement at 12 and 26-weeks? 
4) Does engagement at 12 and 26-weeks predict psychiatric recovery at 12 months 
follow-up? 
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What the study involved 
The study involved gathering data from routinely collected assessments of individuals with 
first episode psychosis and their carers. These assessments were collected as part of an early 
intervention service integrated care pathway. This data was then analysed to help answer the 
research questions.   
 
Results 
At 12-weeks the severity of positive and cognitive disorganisation symptoms, and clinician 
rated lack of insight at baseline were associated with poorer levels of clinician rated 
engagement.  We also found that carers’ burden of care was associated with poorer 
engagement. Additionally, having a higher number of adverse childhood experiences before 
age 16 was also associated with lower levels of engagement. We did not find evidence that 
demographic or psychiatric factors at entry to the service were predictive of engagement at 
12-weeks or 26-weeks. We did however find that a lack of psychiatric insight at entry to the 
service was associated with poorer engagement at 12-weeks. Finally, clinician rated 
engagement at 12 weeks predicted psychiatric recovery at 12 months follow-up.  
 
Conclusions 
Clinicians in early intervention services are well placed to identify those who present with 
lower levels of engagement at earlier stages of treatment and at risk of poorer psychiatric 
outcomes at a later stage. This has implications for treatment planning. Those who lacked 
insight, as rated by clinicians, were also at increased risk of clinician rated poorer 
engagement. Early intervention services should invest in developing novel approaches to try 
and increase engagement in people who lack insight to their diagnosis.  
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Word Count: 449 
Abstract 
Aims: 
 
The effectiveness of early intervention (EI) services for people with first episode psychosis is 
dependent on meaningful service engagement. Difficulties with engagement in EI services increases 
risk of drop out which has implications for poorer functioning and poorer clinical outcomes. The 
purpose of the current study was to explore associations between engagement, clinical, and 
relational variables, and to investigate factors that predict service engagement in an early 
intervention service for first episode psychosis.  
 
Methods: 
The study gathered prospective routine date from an early intervention service using a naturalistic 
cohort of 83 individuals with first episode psychosis in Scotland, UK. Cross sectional associations 
between engagement, attachment, and carer’s burden of care were explored. Sociodemographic, 
clinical and psychiatric predictors of engagement were examined using hierarchical and stepwise 
regression.  
 
 
Results: 
Poorer clinician engagement as measured by the service engagement scale (SES) was associated 
with greater positive symptoms and greater disorganisation, poorer insight, more effortful 
caregiving and higher number of adverse childhood experiences. In regression analysis, only lack 
of insight predicted engagement at 12-weeks. We found that engagement scores at 12-weeks 
predicted engagement at 26-weeks. Additionally, engagement scores at an earlier point of 
treatment were predictive of psychiatric recovery at 12-month follow-up.  
  40 
 
 - 40 - 
 
Conclusions:  
Our findings suggest that clinicians in early intervention services are well placed to identify 
those who are at risk of poorer engagement and subsequent poorer psychiatric outcomes 
which has implications for treatment planning. Additionally, people who lacked insight into 
their diagnosis of psychosis and need for treatment, as rated by clinicians, were rated with 
poorer levels of service engagement.  This may reflect clinicians framework of psychosis 
and mental illness and might suggest the need for clinicians to work within the patients own 
beliefs of their experiences and framework of mental illness to help increase engagement.  
 
 Key words: Early intervention, engagement, first episode psychosis, predictors, 
schizophrenia  
Word Count: 248 
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Introduction  
 
Psychosis and associated disorders are debilitating conditions associated with poorer life 
expectancy, morbidity and lower quality of life (BPS, 2015). Incidence of psychotic 
disorders in the population has been reported as 26.6 per 100,000 with higher rates amongst 
men and ethnic minority populations (Jongsma et al., 2019). Each individual’s experiences 
of psychosis are unique and can include hallucinations, delusions, cognitive and 
interpersonal difficulties and changes in mood. Such experiences can be distressing and 
disabling, particularly when experienced for the first time. The complex interplay of 
biopsychosocial factors often underlies experiences of psychosis with reaction to stressful 
and traumatic life events often playing a pivotal role (Lataster et al., 2012). Early 
intervention (EI) services for first episode psychosis (FEP) have been shown to be clinically 
and cost-effective in managing the critical early stages of psychosis (McCrone et al., 2010) 
Such services are based on the evidence that a longer duration of untreated psychosis (DUP) 
is associated with poorer clinical and functional outcomes (Marshall et al., 2005) and that 
early intervention is shown to be superior to treatment as usual (Correll et al., 2018).  
Disengagement from EI services is associated with negative outcomes including a more 
chronic course of illness, increased need for hospitalisation and higher levels of functional 
disability (Kane et al., 2012). Poor clinician rated engagement in EI services has also been 
linked with higher levels of positive and negative symptoms, and poorer premorbid social 
adjustment (Macbeth et al., 2013).  Groups previously associated with higher likelihood of 
disengagement include those with comorbid substance misuse and those with less family 
support (Doyle et al., 2014). Incidences of FEP are much higher in people from black and 
minority ethnic (BAME) backgrounds in the UK (Fearon et al., 2006) with complex patterns 
of discrimination making it less likely that these groups will seek help (Nicholls et al., 2007). 
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Engagement in mental health services is generally poor (O’Brien et al., 2007) and 
particularly concerning amongst young adults with FEP who have been identified as a 
challenging population to engage (Dixon et al., 2016). Specialist support offered by EI 
services typically involves intensive case management delivered by a multidisciplinary team 
with a focus on fostering a therapeutic relationship with the individual to increase the 
likelihood of success and engagement in recovery. The relationship between the individual 
and service provider is an important focal point in providing treatment and qualitative 
research has identified a strong therapeutic alliance as integral to the success of any 
intervention amongst individuals with FEP (Tindall et al., 2018). 
Poor clinician rated engagement in EI services has also been linked with higher levels 
of positive and negative symptoms, and poorer premorbid social adjustment (Macbeth et al., 
2013).  It has been reported that approximately a third of people with FEP disengage from 
services, with rates of disengagement ranging from 20.5% to 50% (Doyle et al., 2014). 
However, reported rates are inconsistent. An Australian study by Kim and colleagues (2019), 
which employed robust measures using a large epidemiological cohort (n=700) of treated 
cases of FEP, found the rate of disengagement higher than previously reported with over half 
a cohort (56.3%) disengaging. In contrast, a prospective study by Zheng et al., (2013) using 
a cohort of FEP in Singapore (n=775) reported low disengagement rates of 14% over a two-
year period. However, participants with a history of substance abuse were excluded from 
their sample despite this being a widely accepted predictor of disengagement in EI services 
(Doyle et al., 2014). Direct comparison between studies is also made difficult by 
heterogenous definitions of engagement and differences in methodological approaches. For 
example, whilst Zheng and colleagues (2013) included those who have moved out of the 
area as ‘disengaged,’ Kim and colleagues did not (2019). It is possible that cultural 
differences across samples also contribute to varying levels of disengagement. Chan et al., 
(2014) studying disengagement in a FEP sample from Hong Kong (n=700) and including 
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participants with substance abuse, found low rates at 13%. However, the level of substance 
abuse in their sample was much lower to that of FEP populations in Western countries.  
A recognised problem is the lack of consensus on a gold standard definition of 
“engagement” or “disengagement” (Doyle et al 2014; Reynolds et al., 2019) and studies are 
often criticised for viewing these as two concrete dichotomies (Reynolds et al., 2019) which 
fail to capture multi-faceted nature of engagement. For example, one of the most common 
measures reported for disengagement is ‘dropping out’ of treatment (Lal & Malla, 2015) 
which suggests that engagement is an outcome rather than a process. Few studies report on 
the dynamic nature of engagement or that individuals can disengage and re-engage a number 
of times throughout their care. For example, in a prospective cohort, Kim et al. (2019) found 
that 85.5% of those who dropped out of treatment later re-engaged. 
Engagement is a complex phenomenon and has been described as more than that of 
a physical presence, encompassing factors such as “acceptance of a need for help, the 
formation of a therapeutic alliance with professionals, satisfaction with the help already 
received and a mutual acceptance and working towards shared goals” (O’Brien et al, 2009).  
Definitions of engagement amongst the research literature differ between quantitative and 
qualitative studies. Within the qualitative research, there is a real emphasis of the therapeutic 
relationship (Tindall et al., 2018; Loughlin et al., 2019) and the integration of this within EI 
services to enable continued engagement. Farrelly and colleagues (2016) exploring joint 
crisis planning between service users and clinicians found that the clinicians’ goals were 
often at odds to that of the service user. Clinicians motivations to comply with organizational 
requirements, particularly in line with mitigating risk, often undermined the therapeutic 
relationship. An individuals’ desire to engage with an EI service is likely motivated by how 
they perceive the service and support offered to them with evidence showing disengagement 
can arise from a lack of shared purpose and response to individual circumstances, and 
inadequate mental health service systems in EI (Tindall et al., 2020).  
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Family and carers can play a critical role in supporting individuals experiencing FEP 
in their recovery (Lester et al., 2011). However, they too can be adversely impacted by FEP 
by experiencing high levels of distress and burden, particularly when compared to carers of 
those with long term complex physical conditions (Magiliano et al., 2006).  A UK study 
exploring distress in carers of FEP found associations between higher carer burden and 
compulsory admission of individuals with FEP, particularly amongst black Caribbean 
groups (Boydell et al., 2014). Family intervention in EI services, through supporting families 
to understand and respond appropriately to psychosis, is a crucial aspect of care proven to 
improve outcomes and reduce relapse rates (Knapp et al., 2014).  
A recent systematic review reported that only four out of thirty studies under review 
used a valid measurement tool to assess engagement (Reynolds et al., 2019).  Some of the 
current validated questionnaires available for measuring service engagement include the 
Service Engagement Scale (SES; Tait et al., 2003) the Service Engagement Measure (SEM; 
Hall et al., 2001) and the Singh-O’Brien Level of Engagement Scale (SOLES; O’Brien et al, 
2009) which offer clinician rated service engagement. Although helpful to have validated 
tools to measure engagement, the current tools that are available are clinician rated and 
therefore do not consider the service user’s view in engagement which is paramount if we 
are to fully understand factors that contribute to engagement in FEP.  
 A challenge when reviewing the literature is that lack of clarity regarding time 
frames used to define disengagement (Reynolds et al., 2019). When validated tools are not 
used, it is often unclear whether time frames are arbitrary, or reflect a number of missed 
appointments that reach a subjective limit of ‘disengagement.’ Stage of recovery is another 
important consideration when assessing disengagement which is often overlooked; for 
example, an individual who disengages when acutely unwell is somewhat different to a 
person who disengages towards the end of their treatment following improvement in 
clinical outcomes.  Without the use of a comparable outcome measures or an agreed upon 
definition of engagement, our understanding of engagement remains an ongoing challenge 
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in terms of being able to make meaningful comparisons between studies and generate 
conclusions on the dynamic nature of engagement in early intervention services.  
 Factors associated with service engagement in FEP are still poorly understood; 
however, there is growing literature examining associated predictors. Doyle and colleagues 
(2014) systematically reviewed ten articles and identified comorbid substance abuse and 
lack of family involvement or support as being the most robust predictors of disengagement 
in FEP. Such findings are echoed in more recent literature indicating substance abuse as a 
predictor of disengagement (Kim et al., 2019; Solmi et al., 2017, Lau et al., 2017) and lack 
of family involvement (Leclerc, 2015) increasing risk of disengagement. Lack of 
employment, education and training (Kim et al., 2019), duration of untreated illness (Solmi 
et al., 2018), beliefs about the cause of mental illness (Kim et al., 2019) have also been linked 
with disengagement from EI services. However, there lacks consensus regarding severity of 
symptoms and there are often contradictory findings (Doyle et al., 2014). 
There is inconsistent evidence regarding the influence of black, asian and minority 
ethnic (BAME) status on levels of engagement with some studies showing greater 
disengagement in BAME groups (Wang, 2007; Zheng et al., 2013) whilst other have not 
(Solmi et al., 2018; Casey, 2016). Difficulties exist regarding meaningful comparison of the 
influence of ethnicity in engagement due to the lack of studies exploring specific ethnic and 
cultural factors. However, there is evidence that compared to White British populations, 
Black Caribbean and Black African patients experience worse clinical outcomes with 
regards to treatment for psychosis with persistent social disadvantages in Black Carribean 
and Black African patients contributing to such health inequity (Morgan et al., 2017). A 
recent meta-analysis (Anderson et al., 2014) found that ethnicity may have an impact on care 
pathways due the influence of help seeking behaviour and models of illness; however, 
studies in this area were sparse making conclusions difficult. A systematic review and meta-
analysis by Schoer and colleagues (2019) found no differences in DUP for BAME compared 
to White groups; however Black-African groups had a shorter DUP whereas Black-
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Carribean groups had a longer DUP compared to White groups suggesting the need for 
informed targeting of EI for minority populations.  Maraj and colleagues (2018) 
investigating immigrant status on engagement found differences in predictors of engagement 
between first and second generation immigrants in a cohort of FEP in Canada. Immigrants 
were found to be three times more likely than non-immigrants to disengage from treatment 
in EI services (Ouellet-Plamondon et al., 2015). These are notable findings given that 
immigrants are at a higher risk of developing a psychotic disorder than non-immigrants 
(Bourque et al.,2011), although less likely to access care (Thomson et al 2015).   
Considering the poorer outcomes associated with poorer engagement with EI 
services, it is vital that we understand the predictors of engagement to ensure tailoring of 
assertive outreach and improved delivery of FEP services. At present, there is a lack of 
consensus regarding the clinical correlates and predictors of service engagement, which in 
part reflects differing methodologies such as retrospective versus prospective designs, and 
the use of cross-sectional data which captures engagement as an outcome rather than a 
process. The current study was designed to provide a prospective study of service 
engagement at 12 and 26 weeks, and psychiatric recovery (as measured by decrease of 
psychiatrtic symptoms) at 12 months in a cohort of FEP using specialist EI services. We also 
explored cross sectional associations of service engagement with clinical outcomes, service 
attachment and carers’ distress. We tested the following hypotheses: 
1) Poorer clinician rated engagement at 12-weeks will be correlated, cross sectionally, with 
greater overall symptoms, lower levels of service attachment, higher reports of carer 
distress and more adverse childhood experiences. 
2) Severity of psychiatric, mood and anxiety symptoms at entry to the service will predict 
service engagement at 12 and 26-week follow-up. 
3) Clinician rated service engagement at 12 and at 26-week follow-up will predict 
psychiatric outcomes at 12-month follow-up. 
  47 
 
 - 47 - 
Methods 
Methods 
The study was a prospective cohort study of individuals with a first episode psychosis using 
a specialist early intervention service in NHS Greater Glasgow & Clyde (NHSGG&C), 
Scotland. The original project received appropriate NHS ethical (11/AL/0247) and 
managerial (GN11CP130) approvals to proceed prior to data collection. 
 
Participants 
Participants were individuals with a first episode psychosis in the ESTEEM First Episode 
Psychosis Service in NHSGG&C who provided their informed consent to participate. The 
Esteem service works with those aged between 16-35 year old in the NHS Greater Glasgow 
and Clyde are for up to two years, and provides MDT support to the individual with 
psychosis and their family and supporters. Mainly urban and inner city with higher levels of 
deprivation. Serves a population of 1.2 million. Largest health board. 
 
 
Participants were individuals presenting with a first episode of affective or non-affective 
psychosis as defined by the DSM-IV criteria (American Psychiatric Association, 1994).  
Exclusion criteria included individuals who did not consent to take part in the study. 
Participants and their carers were asked for their informed consent to participate in the study 
when referred to the early intervention service.  
 
Measures 
Data were taken from measures that are routinely collected by mental health staff as part of 
an integrated care pathway at entry to the service, 12-weeks, 26-weeks and 1-year follow-
up.  
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Positive and Negative Syndrome Scale (PANSS, Kay, Flszbein & Opler, 1987) is a 30 item 
semi-structured interview which measures current symptoms on a Likert scale from minimal 
(1) to extreme (7). The five-factor scoring method (Van der Gaag et al., 2006) was used as 
this offers a better representation of the dimensional structure of the PANSS data compared 
to the original three sub-scale structure (Wallwork et al., 2012). The five subscales of the 
PANSS cover the following symptomology; positive, negative, cognitive/disorganisation, 
excitement, and distress. The PANSS has a high internal consistency, adequate external 
validity and test-retest reliability (Kay et al., 1987; 1998), and good inter-rater reliability 
(Peralta & Cuesta, 1994). For analysis of insight, the insight item (D7) from the PANSS was 
included on top of the five subscales. Higher scores on the PANSS indicates higher severity 
of symptoms on subscales, and less acceptance of illness and need of treatment for the insight 
item. PANSS was administered at entry to the service, 12 weeks and 26 weeks, and at 12 
months routinely by clinicians in the ESTEEM service.  The internal consistency for all 
PANSS items in the current study was  =0.895 (95%CI=0.859-0.926); however, internal 
consistency for each subscale varied with the following results; PANSS positive  = 0.436 
(95%CI=0.222-0.607), PANSS negative =0.905 (95%CI=0.869-0.934), PANSS cognitive 
disorganisation =0.883 (95%CI=0.840-0.918) PANSS emotional distress  = 0.658 
(95%CI=0.533-0.759). Variations across PANSS subscales was likely due to the use of 
routine data and administration of the measures by different clinicians in the ESTEEM 
service. All clinicians attended a one-day training in the use and scoring of the PANSS and 
participated in calibration sessions. Clinicians were followed up by a Research Assistant 
who provided support in ensuring ratings were made on time and to answer questions about 
scoring.  
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Hospital Anxiety and Depression Scale (HADS, Zigmond and Snaith, 1983) is a widely used 
self-report questionnaire with 14 items to assess distinct dimensions of anxiety and 
depression in non-psychiatric populations. Both anxiety and depression subscales of the 
measure have high internal consistency amongst individuals diagnosed with schizophrenia 
(Sellwood et al., 2013). The HADS was administered to individuals at entry to the service, 
at 12 and 26 weeks and at 12 months by clinicians in the ESTEEM service. Internal 
consistency for anxiety and depression subscales in the current study were with α=0.858 
(95%CI=0.803-0.9.03) and 0.867 (95%CI=0.814-0.908) respectively 
 
Involvement Evaluation Questionnaire (IEQ, Schene et al., 1993) is a 31-item questionnaire 
completed by caregivers. Items have four subscales measuring; tension, supervision, 
worrying and urging. The internal consistency of IEQ subscales are satisfactory in other 
studies (Wijngaarden et al., 2000). The IEQ was administered to carers of individuals using 
the service by ESTEEM clinicians at entry to the service, 12 and 26 weeks and at 12 months. 
Internal consistency in the current study was =0.815 (95%CI=0.707-0.897) and ranged 
from  = 0.735  to  = 0.858 across subscales. 
 
Service Engagement Scale (SES) – Tait et al., 2002 
These SES is a 14-item clinician completed scale to asses overall engagement with services. 
Items assess four subscales; availability, collaboration, help-seeking, and treatment 
adherence. The scale has good reliability and discriminant validity, α=0.76-0.90 for 
subscales (Tait et a., 2014). The SES was completed by clinicians at 12 and 26 weeks and at 
12 months. The SES is utilised by the service to help identify where clinicians are struggling 
to engage service users and directly informs team formulation discussions at 12-weeks 
following service entry. Internal consistency of the SES in the current study was =0.88 (CI 
95%=0.837-0.916). The following internal consistency was reported for SES subscales; 
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availability =0.583 (95%CI=0.399-0.717) collaboration =0.855 (95%CI=0.791-0.902) 
help seeking =0.871 (95% CI=0.818-0.913), treatment adherence =0.848 (95%CI=0.786-
0.896). 
 
Service Attachment Questionnaire (SAQ Goodwin et al., 2003) is a self-report measure 
assessing the security of attachment to staff members, with a higher score indicating greater 
security attachment to the service. It has good internal consistency (Blackburn et al., 2010) 
and test-retest reliability (Goodwin et al., 2003). The SAQ was completed by participants at 
12 and 26-weeks and 12 months. The internal consistency of the SAQ in the present study 
was lower than what would be expected =0.48 (95%CI=0.143-0.729).  
 
Adverse Childhood Experiences measure (ACES) was adapted from Adverse Childhood 
Experiences Study Questionnaires (ACES) (Felitti et al., 1998) which is a 25-item self-report 
measure that assesses the relationship of health risk behaviour and disease in adulthood to 
the breadth of exposure to childhood emotional, physical, or sexual abuse, and household 
dysfunction during childhood. A checklist was developed by the service for staff to routinely 
complete as part of their assessment pathway during the first 12-weeks. The checklist served 
as a prompt for staff to routinely and sensitively enquire about adverse early childhood 
experiences. 
 
Data Analyses 
Sample size and power 
Power analyses were conducted using Gpower 3.0 on Mac to calculate effect sizes for 
multiple regressions to predict engagement scores at 12-weeks and 26-weeks, and 
psychiatric outcomes at 12-months. For predicting engagement at 12-weeks using nine 
predictor variables; age, gender, no education employment or training (NEET), living alone, 
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black, asian and minority ethnic (BAME), PANSS insight, PANSS total, and  HADS anxiety 
and depression scales, and assuming a range of medium to large effect sizes from 0.15 to 
0.35 and =0.5, the power was estimated to be between 0.62 and 0.97 (see appendix 2.2). 
There were n=71, n=75 and n=60 participants’ full data available for each of the planned 
regressions. Therefore, non-significant clinical variables were omitted from subsequent 
analyses to minimise overloading regression models. 
Data were analysed using SPSS version 18. Variables were checked for normality 
using the Kolmogorov-Smirvov test. Relationships between variables were examined using 
Pearson correlations for parametric data, and Spearman correlations for non-parametric data. 
Prior to multiple regression analyses, dependent and predictor variables were checked for 
multicollinearity by the examination of an inter-correlation matrix where values above 0.80, 
VIF > 10 (Myers, 1990) and tolerance statistics <0.1 (Bowerman & O’Connell, 1990) 
suggest multicollinearity was problematic. Autocorrelation was checked using the Durbin-
Watson test statistic (Durbin and Watson, 1951) where values of <1 or >3 indicate residuals 
were correlated. Data were checked for outliers using casewise diagnostics to check for 
standard residuals >3 standard deviations. Cooks Distance (Cook & Weisberg, 1982) was 
used to check for measure of influence, where values of >1 would indicate the model was a 
poor fit of the data and that outliers may be present. Linearity and homoscedasticity were 
checked by the examination of standardised residuals scatterplots. Histograms and normal 
probability plots were examined to check for normally distributed residuals.  
The dependent variables; clinician rated engagement and psychiatric outcomes, were 
entered into multiple regression analyses: hierarchical and stepwise. The hierarchical 
method was selected to allow variables of interest to be added to the model and to investigate 
the contribution of predictors that have inconsistent support in the literature regarding their 
relationship to service engagement in FEP. Stepwise was selected because the hierarchical 
models included non-significant predictors where these variables did not contribute 
significantly to the model.   
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Study variables were selected a priori based on previous research findings. The 
planned order of measures entered into the hierarchical regression to explore associations 
with service engagement at 12 weeks were; age, gender, NEET, living alone, BAME, and 
psychiatric severity at baseline which included; PANSS insight, PANSS total and anxiety 
and depression scales. This combination was repeated using service engagement at 26 weeks 
with the addition of 12-week SES scores as a final step in the model. Measures were entered 
in this order to control for demographic variables before evaluating the contribution of 
clinical symptoms on engagement. All predictor variables were entered for the stepwise 
method with 12 weeks and then 26 weeks as the dependent variable. Predictor variables 
‘living alone’, ‘NEET’ and ‘BAME’ were coded as dichotomous variables (‘yes/no’). 
The final regression looked to answer whether psychiatric outcomes at 12 months was 
associated with clinician rated engagement at 12 and 26 weeks. The planned order of 
measures entered here were; age, gender, NEET, living alone, and BAME status, and then; 
psychiatric, mood and anxiety scores at entry to the service were added, followed by service 
engagement at 12 and 26 weeks. All predictor variables were entered into the stepwise 
regression with total PANSS score at 12 months as the dependent variable. Sensitivity 
analyses were conducted using SES and PANSS subscales as dependent variables on their 
respective multiple regression models. 
 
Results  
Demographics and clinical characteristics 
Of 113 people referred to the service, 2 were unable to provide informed consent, 8 were 
unavailable for consent and 23 declined consent to participate, leaving 83 (73.5%) 
participants who took part in the study. The mean age of participants was 25.64 years old 
(SD=5.51; IQR 20.87-30.50); 55 (66%) were male, 28 (34%) were female. Descriptive data 
for personal characteristics are presented in table 1.  
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Engagement and Clinical Correlates 
Table 1 Summary Statistics for the sample at entry to the service (n=83)            
n (%) of total sample Mean (SD) Median (IQR) 
Sex 
   
Male 55 (66) 
  
Female 28 (34) 
  
Black, Asian and Minority 
Ethnic (BAME)  
   
Yes 19(23) 
  
No 64 (77) 
  
Not in Education, 
Employment or Training 
(NEET) [N%], n=80 
   
Yes  34 (42.5) 
  
No 46 (57.5) 
  
Living alone at entry to 
service [N%], n=82 
   
Yes 15 (18) 
  
No 67(82) 
  
HADS Anxiety ‘Caseness’ 
[N(%), n=74] 
   
Yes 46 (55)   
No 28 (34)   
HAS Depression ‘Caseness’ 
[N(%), n=74] 
   
Yes 35 (47)   
No  39 (53)   
Childcare Responsibilities 
   
Yes 10 (12) 
  
No  73 (88) 
  
Age at entry to service  
 
25.64 (5.51) 25.08 (20.87-30.50) 
Number of ACES before 16 
[n=48) 
 3.23 (2.61) 2.5 (1-5) 
PANSS Positive Syndrome 
[n=82] 
 
21.11(5.19) 21(18-25) 
PANSS Negative Syndrome 
[n=82] 
 
16.44 (9.18) 13 (7-42) 
PANSS 
Cognitive/Disorganisation 
[n=82] 
 24.48 (10.23) 24 (18-31) 
PANSS Excitement [n=82]  9.45 (5.26) 8 (5-13) 
PANSS Emotional Distress 
[n=82] 
 12.34 (5.26) 13 (8-16) 
PANSS Insight (D7) [n=82]  3.99 (1.83) 4 (3-6) 
PANSS Total [n=82] 
 
83.78 (24.62) 83 (67.5-100) 
HADS Anxiety [n=74]  10.2(5.06) 9(6-14.25) 
HADS Depression [n=74]  8.23 (5.46) 7.5(5-12) 
ACES indicates Childhood Adverse Experiences; PANSS indicates Positive and Negative Syndrome Scale; HADS indicates 
Hospital and Anxiety Depression Scale 
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Cross-sectional correlational analysis was conducted using 12-week data to investigate 
associations between clinician rated engagement and symptom severity, service attachment 
and carers’ distress. There was a statistically significant, moderate positive correlation found 
between engagement and positive symptoms (r = 0.32, p<0.01), cognitive/disorganisation 
(r=0.35, p<0.01) and insight (r = 0.42, p<0.01) suggesting participants who were rated as 
more difficult to engage had higher severity of positive and cognitive disorganisation 
symptomology, and less acceptance of illness and needing of treatment. Associations were 
found between more effortful care from caregivers (r=0.32, p<0.05). We found that number 
of adverse childhood events was associated with engagement (r=0.35, p<0.05). There were 
no associations between service engagement and service attachment, albeit the sample size 
available for the SAQ was limited (n=27). Correlations between engagement subscales and 
clinical variables are detailed in table 2. 
  
Chapter 2 
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Table 2 Correlates of Service Engagement at 12-weeks  
 
PANSS 
Positivea 
PANSS 
Negativeb 
PANSS 
Cog Disa 
PANSS 
Excitementb 
PANSS 
Emotional 
Distressa 
PANSS 
Insighta 
HADS 
Anxietya 
HADS 
Depressiona 
SAQ 
Totalb 
IEQ 
Tensiona 
IEQ 
Supervsionb 
IEQ 
Worryinga 
IEQ 
Urginga 
IEQ 
Totala ACEb 
SES Totala 0.32** 0.16 0.35** 0.20 -0.03 0.41** -0.20 -0.02 -0.06 0.31 0.17 0.28 0.30 0.32* 0.35* 
SES 
Availabilityb 0.22 -0.12 -0.03 0.12 -0.06 0.10 0.81 -0.08 -0.12 0.28 0.34* 0.31* 0.25 0.36* 0.21 
SES 
Collaborationa 0.25* 0.20 0.34** 0.24* -0.11 0.32** -0.22 -0.10 -0.07 0.35* 0.31 0.32* 0.23 0.36* 0.26 
SES Helpa 0.20 0.28* 0.32** 0.11 0.08 0.36** -0.11 -0.13 0.14 0.15 0.09 0.16 0.10 0.15 0.37* 
SES 
Adherencea 0.28* 0.04 0.23* 0.17 -0.05 0.30** -0.26* -0.27* -0.8 0.17 0.04 0.07 0.14 0.12 0.24 
∗∗Correlation is significant at the 0.01 level (2-tailed); ∗Correlation is significant at the 0.05 level (2-tailed).  a Pearson r, b Spearman rho. SES: Service Engagement Scale; PANSS: Positive and Negative Syndrome 
Scale; HADS: Hospital Anxiety and Depression Scale; SAQ: Service Attachment Questionnaire; IEQ: Involvement Evaluation Questionnaire; ACE: Adverse Childhood Experiences before age 16 
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Predictors of engagement at 12 and 26-weeks. 
All assumptions necessary for multiple regression were satisfied, with the exception of SES 
scores at 26-weeks which casewise diagnostics indicated one case with a standard residual of 
3.032. The decision was made not to trim the data given this standard residual was only slightly 
above the value of 3. 
Hierarchical (blockwise entry) and stepwise multiple regression analyses were 
performed to examine hypotheses that severity of psychiatric, mood and anxiety symptoms at 
entry to the service will be correlated with service engagement at 12 and 26-weeks follow-up. 
The results for the multiple regression analyses for service engagement at 12 and 26-weeks are 
presented in table 3 and 4. 
 
Predictors of engagement at 12-weeks 
A multiple hierarchical regression was run to predict engagement at 12-weeks, controlling for 
demographic variables. At step 1 the following demographic variables were entered; age, 
gender, living along, NEET, and BAME status which gave an R2 of 0.04 and adjusted R2 of -
0.04, and was not significant. On step 2, psychiatric, mood and anxiety symptoms were added 
to the model with an adjusted R2 of 0.04 and R2 of 0.17 which again was not significant. The 
full model of demographic variables, and psychiatric, mood and anxiety symptoms was not 
statistically significant, R2=0.17, F(9,61)=1.34, p=0.23, adjusted R2=0.04. Multiple regression 
results including regression coefficients are presented in table 3. Sensitivity analyses were 
conducted using subscales from the SES; availability, collaboration, help seeking and treatment 
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adherence, as dependent variables and confirmed the model was replicable as no significant 
predictors emerged.   
When all predictor variables (n=13) were entered into the model, the stepwise method 
indicated that only PANSS insight was significant for inclusion into the model and accounted 
for 9.9% of the variance, with R2=0.11, F(1,69)=8.72 p=<0.005, adjusted R2=0.10.  
Table 3. Multiple Regression Analysis for Engagement at 12-weeks (n=71) 
 R R
2 Adjusted 
R2 
F Sig. 
of F 
B (CI 95%)  Partial r* 
Hierarchical Model         
Age 0.20 0.04 -0.04 0.53 0.75 0.07 (-0.32, 0.34) 0.005 0.01 
Gender      -0.35 (4.21, 5.51) -0.02 -0.02 
Living Along      -3.09 (-7.54, 1.37) -0.17 -0.18 
NEET      -0.28 (-3.52, 2.95) -0.02 -0.02 
BAME      -1.67 (-6.09, 2.76) -0.10 -0.10 
PANSS Insight 0.41 0.17 0.04 1.34 0.23 1.48 (0.16, 2.80) 0.38 0.28 
PANSS Total      -0.03 (-0.13, 0.06) -0.11 -0.09 
HADS Anxiety      -0.15 (-0.59, 0.28) -0.12 -0.09 
HADS Depression      -0.002 (-0.40, 0.40) 0.01 0.001 
Stepwise model         
PANSS Insight 0.34 0.11 0.10 8.72 0.004 1.30 (0.42, 2.17) 0.34 0.34 
*The standardised regression coefficient or beta and the partial correlation are shown; PANSS: Positive and Negative Syndrome Scale; 
HADS: Hospital Anxiety and Depression Scale; SES: Service Engagement Scale 
 
 
Predictors of engagement at 26-weeks 
Multiple hierarchical regression was conducted to determine predictors of engagement at 26-
weeks (table 4). As HADS anxiety and depression and PANSS total were not significant in the 
previous regression investigating predictors at 12-weeks, these were removed from the model. 
The overall model consisted of demographic variables, PANSS insight and the addition of 12-
week SES scores and explained 19% of the variance and was found to be significant, R2=0.27, 
F(7,67)=3.54, p<0.005, adjusted R2=0.19. At step 1, demographic variables; age, gender, living 
along, NEET and BAME status were entered which gave R2 of 0.03 and adjusted R2 of -0.04 
and was not significant (F=0.47, p=0.80). On step 2 when insight was added to the model R2 
  58 
 
 - 58 - 
was 0.07, adjusted R2 was -0.01 and the increment of change was not significant (F=2.91, 
p=0.09). On step 3 when 12-week SES scores were entered into the model, R2 was 0.27, 
adjusted R2 was 0.19 and the change was significant (F=18.11, p<0.001).  
 When all predictors (n=7) were entered into the model, stepwise regression indicated 
that only SES scores at 12 weeks was significant for inclusion into the model, accounting for 
22.6% of the variance, R2=0.24, F(1,73)=22.62, p<0.001, adjusted R2=0.24. 
  
 
 
Table 4. Multiple Regression Analysis for Engagement at 26-weeks (n=75) 
 R R
2 Adjusted 
R2 
F Sig. 
of F 
B (CI 95%) * Partial 
r* 
Hierarchical Model         
Age 0.18 0.03 -0.04 0.47 0.80 -0.10 (-0.33, 0.35) 0.007 0.008 
Gender      -2.69 (-6.80, 1.07) -0.16 -0.18 
Living Along      0.59 (-4.81, 5,26) 0.03 0.03 
NEET      1.23 (-1.94, 4.39) 0.08 0.09 
BAME      0.32 (-4.45, 5.08) 0.02 0.02 
PANSS Insight 0.27 0.07 -0.01 0.89 0.51 0.21 (-0.89,1.31) 0.04 0.05 
12-weeks SES 0.52 0.27 0.19 3.54 0.00 0.57 (0.30, 0.84) 0.49 0.46 
Stepwise model         
12-weeks SES 0.49 0.24 0.23 22.62 0.00 0.57 (0.33, 0.81) 0.49 0.49 
*The standardised regression coefficient or beta and the partial correlation are shown; PANSS: Positive and Negative 
Syndrome Scale; SES: Service Engagement Scale 
 
 
 
12-month psychiatric symptoms 
Hierarchical multiple regression was run to determine the predictors of psychiatric outcomes 
at 12 months (table 5). The full model of demographic variables, baseline psychiatric scores 
and engagement at 12 and 26-weeks to predict psychiatric outcomes at 12-months was not 
significant, R2=0.17, F(11,48)=0.90, p=0.55, adjusted R2=-0.02.  
When all variables were entered into the stepwise model (n=11), stepwise regression 
showed only 12-weeks SES scores were significant for inclusion into the model for prediction 
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of psychiatric scores at 12 months, accounting for 10% of the variance, R2=0.12, F(1,58)=7.66, 
p<0.01, adjusted R2=0.10. 
  
 
Table 5. Multiple Regression Analysis for Psychiatric Recovery at 12-months (n=60) 
 R R
2 Adjusted 
R2 
F Sig. 
of F 
B (CI 95%)  Partial r* 
Hierarchical Model         
Age 0.16 0.03 -0.06 0.30 0.91 -0.18 (-1.39, 1.037) -0.04 -0.04 
Gender      -1.20 (-15.73, 13.34) -0.02 -0.02 
Living Along      -5.47(-22.29, 11.35) -0.10 -0.09 
NEET      0.04 (-11.99, 12.06) 0.00 0.00 
BAME      2.46 (15.70, 20.62) 0.04 0.04 
PANSS Insight 0.22 0.05 -0.13 0.27 0.98 -1.14 (-6.12, 3.85) -0.09 -0.07 
PANSS Total      0.11 (-0.21, 0.44) 0.12 0.09 
HADS Anxiety      0.82 (-0.79, 2.42) 0.18 0.15 
HADS Depression      -0.74 (-2.15, 0.67) -0.18 -0.15 
12-weeks SES 0.41 0.17 -0.02 0.90 0.55 1.03 (-0.03, 2.11) 0.33 0.27 
26-weeks SES      0.91 (-2.88, 4.71) 0.08 0.07 
Stepwise model n=60         
12 weeks SES  0.34 0.12 0.10 7.66 0.01 1.06 (0.29-1.83) 0.34 0.34 
*The standardised regression coefficient or beta and the partial correlation are shown; PANSS: Positive and Negative 
Syndrome Scale; HADS: Hospital Anxiety and Depression Scale; SES: Service Engagement Scale 
 
 
Discussion 
The first aim of the study was to establish associations between clinician rated engagement 
and psychiatric symptom severity, service attachment and carers’ burden of care at 12-weeks. 
We found that severity of positive and cognitive disorganisation symptoms, and lack of 
insight were associated with poorer levels of engagement and thus the initial hypothesis was 
partially supported. No associations were found between negative symptoms, excitement 
symptoms, emotional distress, anxiety or depression. Some of our findings are consistent with 
previous research. Macbeth et al., (2013) found poorer clinician engagement as measured by 
the SES was also associated with greater positive symptoms and greater psychopathology; 
however, the same study found associations with negative symptoms which was not evident 
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in the present study. Our findings reflect other research which have found associations with 
engagement and cognitive disorganisation (Johansen et al., 2011; Macbeth et al., 2016), and 
insight (Starting et al., 2009; Belvederi Murri et al., 2016).  
We explored the relational aspects of engagement and found associations between more 
effortful caregiving from carers and poorer levels of engagement. Informal support from 
caregivers is invaluable in the early phase of psychosis and research has highlighted the clear 
benefit of a strong relationship between carers and EI services on both supporting carers to 
manage distress (Lavis et al., 2015) and in enhancing service user satisfaction in EI services 
(Lester et al., 2011).  The association between carers’ burden of care and service engagement 
has not previously been noted in the literature. We found that that higher number of ACES 
were associated with poorer engagement. It has been theorised that ACES in childhood may 
hinder the development of attachment security (Bowlby, 1990) and further work is needed to 
understand the contribution of ACES on relational aspects of engagement.  We were interested 
in the associations between service attachment and engagement however no significant findings 
emerged. The lack of association between clinicians’ ratings of service engagement and service 
users’ ratings of service attachment, albeit with a small sample size, merits further research in 
the future.  
Secondly, the hypothesis that severity of psychiatric, mood and anxiety symptoms at entry 
to the service would predict engagement at 12 and 26-weeks was rejected. This is consistent 
previous findings in FEP (Lau et al., 2017; Chan et al., 2014; Stowkowy et al., 2012). Evidence 
for clinical predictors of engagement has been inconsistent in the FEP literature (Doyle et al., 
2014) and whilst some studies have noted the contribution of positive symptoms (Lecomte et 
al., 2008, Turner et al., 2007) and negative symptoms (MacBeth et al., 2013) on engagement, 
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others have not (Maraj et al., 2018; Lau et al., 2017). Stepwise regression found that psychiatric 
insight was predictive of engagement at 12-weeks, albeit the association was small. This 
finding is consistent with research which has suggested insight as being one of the more 
consistent predictors of engagement demonstrated in the literature (Turner et al., 2007, Zheng 
et al., 2013 Doyle, 2014). However, others have found no association (Conus et al.,2008; 
Stowokowy et al., 2012). Insight has an array of different theoretical underpinnings in the 
psychosis literature (McCormack et al., 2013) and different measurements are employed to 
capture this construct which may explain some of the discrepancies amongst the research.  
The hierarchical regression model was not significant in predicting engagement at 26-
weeks and effects of insight was no longer present in the stepwise model, rather 12-week SES 
scores were predictive of engagement at 26-weeks. Lastly it was hypothesised that clinician 
rated engagement at 12 and 26-weeks would predict recovery at 12-months. Hierarchical 
regression did not support this hypothesis; however, the stepwise model suggested clinician 
rated engagement at 12-weeks predicted psychiatric recovery at 12-months. This suggests 
clinician rated engagement during this time frame can be a useful tool in identifying those at 
risk of poorer outcomes and adapting treatment plans accordingly. We found that clinician rated 
service engagement accounted for 10% of the variance in psychiatric recovery. Interestingly, 
the effect found here was larger than that reported in meta-analyses for therapeutic alliance on 
outcomes in adult psychotherapy populations (r=0.274, Del Re et al., 2012). Clinician rated 
engagement therefore could be a useful tool when formulating treatment plans to increase 
treatment outcomes for those at risk of poor engagement and subsequent poorer outcomes. 
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Strengths and Limitations 
Strengths of the present study include clinician engagement with routine collection of data, 
prospective design, use of a validated engagement tool, and good rates of consent (79%) 
However, the study should by reviewed in light of some limitations. Firstly, the current sample 
size was relatively small which has implications for statistical power.  Although we used a 
validated tool for measuring engagement the SES is clinician rated, and it is unclear to the 
extent to which individuals with psychosis and their families agree with the construct used to 
measure service engagement. It is of interest that we found no association between clinician 
rated service engagement and service user ratings of service attachment. This finding merits 
further investigation. It was interesting that with the exception of insight, no other demographic 
or clinical variables were predictive of engagement or recovery. It should be noted that the 
measure used to assess insight was clinician rated, and therefore may not be reflective of, or 
differ quite significantly from, the patient’s own beliefs about mental illness. For example, 
patients who do not share the same understanding of psychosis, or reject their diagnosis may 
be viewed as ‘lacking insight’ by clinicians.  Patients may view their psychosis as helpful or 
even spiritual which might also have an impact on their motivation to engage with services. 
The lack of patient input on their views of illness and their motivation to engage in treatment 
is therefore a limitation in the current study. 
We found weak evidence for more effortful care and higher number of ACES being associated 
with poorer engagement; however, the cross-sectional design limits the conclusions that can be 
drawn from this. Longitudinal and mixed-methods approach investigating relational aspect of 
engagement in EI services would help increase the validity of these findings. 
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 We did not collect demographic data on clinicians who worked at the ESTEEM service 
and such data would have been helpful to comment on issues such as diversity of the staff team. 
It is important that staff can represent, or are familiar with, the various cultures of those using 
their service, and that people from ethnic and minority backgrounds can work with clinicians 
who share similar cultural frameworks.   
 Although rates of consent into the study were 79%, those who did not consent might 
have been rated by staff as having poorer levels of engagement. Therefore, it is possible that 
engagement levels are overestimated in those who use EI services in the given catchment area.  
Finally, the study lacks input from different stakeholders and thus results largely reflect 
the clinician’s framework of understanding psychosis and mental illness. Qualitative accounts 
from service users and their supporters would help further our understanding of individuals 
reasons for engagement in EI services.  
Implications 
The findings of this study have implications for both research and clinical practice. A major 
limitation of the current study, and other studies in the research literature that investigate 
engagement in EI services, is that engagement from the service user perspective is largely 
unheard. Further work is needed to understand how people with FEP and their families 
experience engagement which should help bridge the inherent bias associated with clinician 
rated engagement scales. Factors such as disempowerment, stigma, and changes in clinicians 
have been identified as common reasons for disengagement from the perspective of the service 
user (Tindall et al., 2020) and it is important that such voices are incorporated into how we 
measure engagement in future studies.  
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Previous research has been inconsistent in identifying robust predictors of engagement 
and this has been reflected in our lack of findings. This may have implications for future 
research in in terms of alternative methodologies to investigate engagement. Emerging research 
using complexity science to understand mental health has challenged traditional clinical trials 
and their focus on ‘cause and effect.’ Complexity science argues the necessity to study the 
complex systems which give rise to psychopathology in order to explain, predict and 
successfully intervene (Fried & Robinaugh, 2020). Consideration of such methodologies may 
help enhance our understanding of the complex interplay of biopsychosocial systems that may 
influence engagement in FEP. 
In terms of clinical implications, our findings that stronger engagement in the early 
stages of treatment is linked to better psychiatric recovery reinforces opportunities to improve 
outcomes through the therapeutic relationship.  This is reassuring given the already strong focus 
therapeutic alliance in EI services. We found that insight was a predictor of poorer clinician 
rated engagement in EI services. Individuals who score higher on insight measures may not 
necessarily agree with their diagnosis and may not wish to engage in services. Past research 
has shown that clinicians tend to struggle with individuals who do not ‘fit’ with the service 
model which can lead to uncertainty around the purpose of engagement and decreased 
confidence in supporting such individuals (Tindall et al, 2020). There is a need for clinicians 
to step outside diagnostic labels in such cases and find novel ways to engage people who present 
with lower levels of insight.   
 
  65 
 
 - 65 - 
Conclusion 
In this study using routine data from a naturalistic cohort of FEP patients, severity of positive 
and cognitive disorganisation symptoms, and lack of insight were associated with poorer levels 
of engagement. We also found weaker evidence for more effortful care and higher number of 
ACES being associated with poorer engagement. In regression analysis, lack of insight was 
found as a predictor of poorer clinician rated engagement at 12-weeks, and engagement at 12-
weeks was predictive of later engagement at 26-weeks. We also found clinician rated 
engagement at 12-weeks to be predictive of psychiatric outcomes at 12-month.  
Individuals with poor levels of engagement may be at risk of disengagement from EI 
services which may lead of future relapse and poorer functioning (Conus et al., 2017). These 
findings suggest staff are well placed to identify those at risk of low engagement and 
subsequent poorer recovery which has implications for treatment planning. Additionally, our 
findings add to the existence evidence that suggest lack of insight is a marker for poorer 
engagement, calling for novel approaches to help engage such individuals.  
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Appendix 1:1 Author Guidelines for Submission to Early 
Intervention in Psychiatry 
 
 
Author Guidelines 
Sections 
1. Submission 
2. Aims and Scope 
3. Manuscript Categories and Requirements 
4. Preparing the Submission 
5. Editorial Policies and Ethical Considerations 
6. Author Licensing 
7. Publication Process After Acceptance 
8. Post Publication 
9. Editorial Office Contact Details 
1. SUBMISSION 
Thank you for your interest in Early Intervention in Psychiatry. Authors should kindly note that 
submission implies that the content has not been published or submitted for publication elsewhere except 
as a brief abstract in the proceedings of a scientific meeting or symposium. 
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts 
should be submitted online at http://mc.manuscriptcentral.com/eip 
For any queries regarding submission, please contact eip.eo@wiley.com. 
We look forward to your submission. 
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, 
and other contact details the publication might require, will be used for the regular operations of the 
publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and 
publication. The publication and the publisher recognize the importance of protecting the personal 
information collected from users in the operation of these services, and have practices in place to ensure 
that steps are taken to maintain the security, integrity, and privacy of the personal data collected and 
processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-
policy.html 
  
2. AIMS AND SCOPE 
Early Intervention in Psychiatry publishes original research articles and reviews dealing with the early 
recognition, diagnosis and treatment across the full range of mental and substance use disorders, as well as 
the underlying epidemiological, biological, psychological and social mechanisms that influence the onset 
and early course of these disorders. The journal provides comprehensive coverage of early intervention for 
the full range of psychiatric disorders and mental health problems, including schizophrenia and other 
psychoses, mood and anxiety disorders, substance use disorders, eating disorders and personality disorders. 
Papers in any of the following fields are considered: diagnostic issues, psychopathology, clinical 
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epidemiology, biological mechanisms, treatments and other forms of intervention, clinical trials, health 
services and economic research and mental health policy. Special features are also published, including 
hypotheses, controversies and snapshots of innovative service models. 
In contrast with mainstream healthcare, early diagnosis and intervention has come late to the field of 
psychiatry. Early Intervention in Psychiatry creates a common forum for researchers and clinicians with an 
interest in the early phases of a wide range of disorders to share ideas, experience and data. This journal not 
only fills a gap, but also creates a new frontier in academic and clinical psychiatry. 
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS 
Articles reporting original work that embodies scientific excellence in psychiatry and advances in clinical 
research  (maximum word count for text 3000; abstract 250); 
 
Reviews which synthesize important information on a topic of general interest to early intervention in 
psychiatry. (maximum word count for text 5000; abstract 250); 
 
Brief Reports which present original research that makes a single point, or negative studies of important 
topics (maximum word count for text 1500; abstract 150); 
 
Early Intervention in the Real World, a special features section which focuses on issues such as service 
descriptions and delivery, and clinical practice guidelines (maximum word count for text 3000; abstract 
250); 
 
Editorials or New Hypotheses.  Please contact the editorial office before writing an Editorial or New 
Hypotheses article for the journal (maximum word count for text 1000); 
4. PREPARING THE SUBMISSION 
Wiley Author Resources 
Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for 
submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips 
on Writing for Search Engine Optimization. 
Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, 
as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract 
design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing 
Your Article for general guidance about writing and preparing your manuscript.     
Style 
Spelling. The journal uses UK spelling and authors should therefore follow the latest edition of the 
Concise Oxford Dictionary. 
 
Units. All measurements must be given in SI or SI-derived units. Please go to the Bureau International des 
Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units. 
 
Abbreviations. Abbreviations should be used sparingly – only where they ease the reader’s task by 
reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in 
parentheses. Thereafter use the abbreviation only. 
 
Trade names. Drugs should be referred to by their generic names. If proprietary drugs have been used in 
the study, refer to these by their generic name, mentioning the proprietary name, and the name and location 
of the manufacturer, in parentheses. 
Parts of the Manuscript 
The text file should be presented in the following order: 
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i. A short informative title that contains the major key words. The title should not contain abbreviations 
(see Wiley's best practice SEO tips); 
ii. A short running title of less than 40 characters; 
iii. The full names of the authors; 
iv. The author's institutional affiliations where the work was conducted, with a footnote for the author’s 
present address if different from where the work was conducted; 
v. Abstract and keywords; 
vi. Main text; 
vii. Acknowledgements; 
viiii. Conflict of interest statement; 
ix. References; 
x. Tables (each table complete with title and footnotes); 
xi. Figure legends; 
xii. Appendices (if relevant). 
Figures and supporting information should be supplied as separate files. 
Authorship 
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for 
details on eligibility for author listing. 
Abstract and key words 
All articles must have a structured abstract that states in 250 words (150 words for Brief Reports) or fewer 
the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract 
with the headings: Aim, Methods, Results, Conclusions. The abstract should not contain abbreviations or 
references. 
 
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, 
and should be taken from those recommended by the US National Library of Medicine’s Medical Subject 
Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html. 
Text 
Authors should use the following subheadings to divide the sections of their manuscript: Introduction, 
Methods, Results and Discussion. 
Acknowledgments 
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission 
from the contributor, in an Acknowledgments section. Financial and material support should also be 
mentioned. Thanks to anonymous reviewers are not appropriate. 
Conflict of Interest Statement 
Authors will be asked to provide a conflict of interest statement during the submission process. For details 
on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical 
Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm 
agreement with the final statement. 
References 
References should be prepared according to the Publication Manual of the American Psychological 
Association (6th edition). This means in text citations should follow the author-date method whereby the 
author's last name and the year of publication for the source should appear in the text, for example, (Jones, 
1998). The complete reference list should appear alphabetically by name at the end of the paper. 
A sample of the most common entries in reference lists appears below. Note that for journal articles, issue 
numbers are not included unless each issue in the volume begins with page one, and a DOI should be 
provided for all references where available. 
Journal article 
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Beers, S. R. , & De Bellis, M. D. (2002). Neuropsychological function in children with maltreatment-
related posttraumatic stress disorder. The American Journal of Psychiatry, 159, 483–486. 
doi:10.1176/appi.ajp.159.3.483 
Book 
Bradley-Johnson, S. (1994). Psychoeducational assessment of students who are visually impaired or blind: 
Infancy through high school (2nd ed.). Austin, TX: Pro-ed. 
Internet Document 
Norton, R. (2006, November 4). How to train a cat to operate a light switch [Video file]. Retrieved 
from http://www.youtube.com/watch?v=Vja83KLQXZs 
Tables 
Tables should be self-contained and complement, not duplicate, information contained in the text. They 
should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – 
the table, legend, and footnotes must be understandable without reference to the text. All abbreviations 
must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** 
should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the 
headings. 
Figure Legends 
Legends should be concise but comprehensive – the figure and its legend must be understandable without 
reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units 
of measurement. 
Figures 
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a 
wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements 
for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance 
figure requirements. 
Supporting Information 
Supporting information is information that is not essential to the article, but provides greater depth and 
background. It is hosted online and appears without editing or typesetting. It may include tables, figures, 
videos, datasets, etc. 
Click here for Wiley’s FAQs on supporting information. 
Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available 
via a publicly available data repository, authors should include a reference to the location of the material 
within their paper. 
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS 
Peer Review and Acceptance 
Manuscripts are judged on the significance of the contribution to the literature, the quality of analysis and 
the clarity of presentation. Papers are expected to demonstrate originality and meaningful engagement with 
the global literature. 
Except where otherwise stated, manuscripts are double-blind peer reviewed by anonymous reviewers in 
addition to the Editor. Final acceptance or rejection rests with the Editor-in-Chief, who reserves the right to 
refuse any material for publication. 
Wiley's policy on the confidentiality of the review process is available here. 
Authorship Policy 
The journal adheres to the definition of authorship as set out by The International Committee of 
Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 
criteria: 
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• Substantial contributions to the conception or design of the work; or the acquisition, analysis, or 
interpretation of data for the work; AND 
• Drafting the work or revising it critically for important intellectual content; AND 
• Final approval of the version to be published; AND 
• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy 
or integrity of any part of the work are appropriately investigated and resolved. 
In addition to being accountable for the parts of the work he or she has done, an author should be able to 
identify which co-authors are responsible for specific other parts of the work. In addition, authors should 
have confidence in the integrity of the contributions of their co-authors. All those designated as authors 
should meet all four criteria for authorship, and all who meet the four criteria should be identified as 
authors. 
Human Studies and Subjects 
For manuscripts reporting medical studies that involve human participants, a statement identifying the 
ethics committee that approved the study and confirmation that the study conforms to recognized standards 
is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human 
Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state 
clearly in the text that all persons gave their informed consent prior to their inclusion in the study. 
Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human 
subjects being recognized (or an eye bar should be used). Images and information from individual 
participants will only be published where the authors have obtained the individual's free prior informed 
consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing 
the author license to publish, authors are required to confirm that consent has been obtained. Wiley has 
a standard patient consent form available for use. 
Case Reports. In general, submission of a case report should be accompanied by the written consent of the 
subject (or parent/guardian) before publication; this is particularly important where photographs are to be 
used or in cases where the unique nature of the incident reported makes it possible for the patient to be 
identified. While the Editorial Board recognizes that it might not always be possible or appropriate to seek 
such consent, the onus will be on the authors to demonstrate that this exception applies in their case. 
Use of Animals in Research 
Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant 
conform to national guidelines for animal usage in research. 
Data Sharing and Data Accessibility 
EIP expects that data supporting the results in the paper will be archived in an appropriate public 
repository. Authors are required to provide a data availability statement to describe the availability or the 
absence of shared data. When data have been shared, authors are required to include in their data 
availability statement a link to the repository they have used, and to cite the data they have shared. 
Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper 
should also be publicly archived. If sharing data compromises ethical standards or legal requirements then 
authors are not expected to share it. 
Conflict of Interest 
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or 
relationship, financial or otherwise that might be perceived as influencing an author's objectivity is 
considered a potential source of conflict of interest. These must be disclosed when directly relevant or 
directly related to the work that the authors describe in their manuscript. Potential sources of conflict of 
interest include, but are not limited to: patent or stock ownership, membership of a company board of 
directors, membership of an advisory board or committee for a company, and consultancy for or receipt of 
speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the 
authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility 
of the corresponding author to review this policy with all authors and collectively to disclose with the 
submission ALL pertinent commercial and other relationships. 
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Publication Ethics 
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses 
iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted 
manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics 
Guidelines can be found here. 
ORCID 
As part of the journal’s commitment to supporting authors at every step of the publishing process, the 
journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This 
takes around 2 minutes to complete. Find more information here. 
6. AUTHOR LICENSING 
If your paper is accepted, the author identified as the formal corresponding author will receive an email 
prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they 
will be required to complete a copyright license agreement on behalf of all authors of the paper. 
Authors may choose to publish under the terms of the journal’s standard copyright agreement, 
or OnlineOpen under the terms of a Creative Commons License. 
General information regarding licensing and copyright is available here. To review the Creative Commons 
License options offered under OnlineOpen, please click here. (Note that certain funders mandate that a 
particular type of CC license has to be used; to check this please click here.) 
Self-Archiving definitions and policies. Note that the journal’s standard copyright agreement allows for 
self-archiving of different versions of the article under specific conditions. Please click here for more 
detailed information about self-archiving definitions and policies. 
Open Access fees: If you choose to publish using OnlineOpen you will be charged a fee. A list of Article 
Publication Charges for Wiley journals is available here. 
Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder 
Open Access Policies. 
7. PUBLICATION PROCESS AFTER ACCEPTANCE 
Accepted article received in production 
When an accepted article is received by Wiley’s production team, the corresponding author will receive an 
email asking them to login or register with Wiley Author Services. The author will be asked to sign a 
publication license at this point. 
Proofs 
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs 
online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online 
guidelines are provided within the system. No special software is required, all common browsers are 
supported. Authors should also make sure that any renumbered tables, figures, or references match text 
citations and that figure legends correspond with text citations and actual figures. Proofs must be returned 
within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online 
system cannot be used or accessed. 
Early View 
The journal offers rapid speed to publication via Wiley’s Early View service. Early View (Online Version 
of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a 
delay after corrections are received before the article appears online, as Editors also need to review proofs. 
Once the article is published on Early View, no further changes to the article are possible. The Early View 
article is fully citable and carries an online publication date and DOI for citations. 
8. POST PUBLICATION 
Access and sharing 
When the article is published online: 
  78 
 
 - 78 - 
• The author receives an email alert (if requested). 
• The link to the published article can be shared through social media. 
• The author will have free access to the paper (after accepting the Terms & Conditions of use, they can 
view the article). 
• The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert 
and free online access to the article. 
Print copies of the article can now be ordered (instructions are sent at proofing stage). 
Article Promotion Support  
Wiley Editing Services offers professional video, design, and writing services to create shareable video 
abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so 
you can help your research get the attention it deserves. 
Measuring the Impact of an Article 
Wiley also helps authors measure the impact of their research through specialist partnerships 
with Kudos and Altmetric. 
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Professor Patrick McGorry, Editorial Office, Early Intervention in Psychiatry 
C/O Wiley 
155 Cremorne St 
Richmond, Victoria, 3121 
Australia 
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Appendix 2.2  Power Calculation  
 
 
Figure 2: Post hoc power calculation for multiple regression (n=83) 
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Appendix 2.3 Ethical Approval for Access to Secondary 
Data 
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Appendix 2.3  Covid-19 Suspension of Recruitment Letter 
 
 
 
Dr Karen Bell 
R&D Manager 
Research & Development Team 
60 Lister Street 
University Hospital Crosshouse 
Kilmarnock 
KA2 0LB 
T: 01563 825850 
E: Karen.Bell2@aapct.scot.nhs.uk 
 
13th March, 2020 
 
Dear Principal Investigator / Research Team 
Covid-19: Suspension of recruitment to all hosted clinical trials/studies in NHS GG&C 
In order to address the current and potential implications of the rapidly developing COVID-
19 outbreak on our patient population, clinical and research teams, we have taken the difficult 
decision to suspend recruitment into all* clinical research studies within NHS Ayrshire & 
Arran.      
This is an urgent safety measure being taken to ensure that patients, carers and staff, 
particularly those with (or who are in routine, close contact with others who have) underlying 
health conditions are not put at any unnecessary risk.   The decision has been taken in close 
consultation with National Research Scotland and Chief Scientist Office colleagues, and 
mirrors actions being taken in all Scottish NHS Boards.   Please contact your local R&D 
Office if you wish to discuss the undernoted advice, which will be updated as required. 
As of Monday 16th March, please do not approach any patient regarding clinical study 
participation.     
*A small number of exceptions to the above decision may apply as follows: 
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Patients who have already signed informed consent may continue to screen and register for a 
trial BUT ONLY where the investigator considers it safe in light of the prevailing situation, 
and it is in the patient’s best interests to do so.   The decision to continue as described, in light 
of this guidance, must be recorded in the Investigator Site File and patient notes, and notified 
to the R&D Office as an exception (see below). 
• All activities related to current or upcoming Covid-19 research studies should continue 
where safe to do so 
• Patients may, at the PI’s discretion, still be approached about observational studies, pre-
screening studies, etc., where this participation requires no additional hospital attendance 
by the patient 
• Patients may be enrolled in a study that the patient’s treating physician considers to be 
providing “essential clinical care” 
If you wish to apply any of the above exceptions, you should notify the R&D Office using the 
following email address BEFORE proceeding: Karen.Bell2@aapct.scot.nhs.uk.   Please 
include the following details of the study (PI, IRAS number, Title) along with a justification, 
and plan for ongoing recruitment including the availability of study specific staff. 
At this stage follow up visits for currently-enrolled patients that involve face-to-face contact, 
either in hospital or at the patient’s home, should be postponed with immediate effect and 
until further notice to mitigate the impact of COVID-19 unless the visits are deemed vital for 
patient safety purposes.   In such circumstances, the PI should always assess the risk and act 
in the patient’s interests. 
Research teams are asked to comply with the following: 
1) Work with sponsors to agree arrangements for carrying out follow-up (hospital or at-
home) visits remotely wherever possible 
2) Maintain contact with your patients to provide reassurance, to let them know about 
any changes in arrangements, and to encourage them to remain within the study 
3) Postpone any external monitoring visits unless there is a subject safety issue. Where 
possible please make arrangements to participate in remote monitoring  
4) Postpone any site initiation visits or site selection visits unless they involve studies 
related to COVID-19  
5) Protocol deviations- The MHRA expect there to be an increase in protocol deviations 
but have requested that these are documented in the normal manner   
6) IMP supplies for our hosted CTIMPs should be discussed with Sponsors and with 
your local Pharmacy team who support your study.   All patients should continue to 
receive their Investigational Medicinal Product (IMP) if you as PI (or in discussion 
with the CI/Sponsor) deem this the right thing to do. Supply of these medications 
should be carried out in a manner deemed to be of lowest risk. If a courier is to be 
used, Participants must consent verbally to providing contact details for these shipping 
purposes. 
MHRA advice is available at  https://mhrainspectorate.blog.gov.uk/2020/03/12/advice-for-
management-of-clinical-trials-in-relation-to-coronavirus/ 
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HRA advice is available at https://www.hra.nhs.uk/planning-and-improving-
research/policies-standards-legislation/covid-19-guidance-sponsors-sites-and-researchers/ 
 
Finally, for now, we recognise that our colleagues throughout the service are responding to an 
unprecedented set of circumstances.   It may be that our research staff are asked to support the 
efforts of colleagues in providing care as this stress on the system continues.   We will expect 
that research support staff will do whatever they can, while also recognising that a significant 
volume of research activity will continue – increasing SAE, AE, Protocol deviation reporting, 
ongoing follow-up, new activities seeing patients remotely.    We will at all times respond 
pragmatically, and provide whatever capacity is available when requested. 
Please forward this letter to the sponsor and chief investigators.   Ongoing contingency 
planning is underway and further correspondence will follow should the situation change. 
Should have any queries please direct them to myself or Danielle Gilmour 
Danielle.Gilmour@aapct.scot.nhs.uk. 
Yours sincerely, 
 
Dr Karen Bell 
R&D Manager, NHS Ayrshire & Arran 
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Appendix 2.5 Ethical Approval for EXPAND 
  
 
 
           
Professor Andrew Gumley 
Mental Health and Wellbeing 
Gartnavel Royal Hospital,  
1st Floor, Admin Building 
University of Glasgow 
Glasgow 
G12 OXH 
  
West of Scotland REC 3 
Research Ethics  
Clinical Research and Development 
Dykebar Hospital 
Grahamston Road 
Paisley PA2 7DE 
  
Date 02 April 2020 
Direct line 0141  314 0211 
E-mail WoSREC3@ggc.scot.nhs.uk 
 
Dear Professor Gumley  
 
Study title: Exploring the experiences of people with psychosis and type 2 
diabetes: A qualitative Study 
REC reference: 20/WS/0021 
Protocol number: 264580 
IRAS project ID: 264580 
 
Thank you for your email of 13 March 2020, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information was considered in correspondence by a Sub-Committee of the REC  A 
list of the Sub-Committee members is attached.   
 
Confirmation of ethical opinion 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation 
as revised, subject to the conditions specified below. 
 
Conditions of the favourable opinion 
The REC favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
 
Confirmation of Capacity and Capability (in England, Northern Ireland and Wales) or NHS 
management permission (in Scotland) should be sought from all NHS organisations involved in 
the study in accordance with NHS research governance arrangements.  Each NHS organisation 
must confirm through the signing of agreements and/or other documents that it has given 
permission for the research to proceed (except where explicitly specified otherwise). 
 
WoSRES 
West of Scotland Research Ethics Service 
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Appendix 2.6 EXPAND Participant Information Sheet 
 
 
 
 
 
 
 
 
 
 
 
 
Exploring the Experiences of People with Psychosis and Type 2 Diabetes 
(EXPAND): Participant Information Sheet (Version 2.0 24th January 2020). 
 
1. What will participation involve? 
You are being invited to take part in this research study because a member of your 
care team thought you might be interested in participating. The aim of the research 
project is to explore the experiences of people who have psychosis and type 2 
diabetes.   
 
Before you decide, it is important for you to understand why the research is being 
done and what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. Please ask if there is anything that 
is not clear or if you would like more information.  
 
Participation is voluntary and you do not have to take part if you do not wish to. You 
will continue to receive the best quality of care whether you take part or not.  
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If you decide to take part in this study, you will be given a copy of this Participant 
Information Sheet and the signed consent form to keep. 
 
2. Who is conducting the research? 
The research is being carried out by Kirsty McPhilemy who is a clinical psychologist 
in training from the University of Glasgow. The research is being supervised by 
Professor Andrew Gumley, Professor of Psychological Therapy from the University 
of Glasgow, and Dr Everett Julyan, Consultant Psychiatrist from NHS Ayrshire & 
Arran.  
3. What is the purpose of the study? 
The purpose of the study is to try and better understand the experience of living 
with psychosis and type 2 diabetes. The study is being carried out as part of the 
requirements of the Doctorate in Clinical Psychology training course at the 
University of Glasgow. 
The study will involve talking to people who have a diagnosis of psychosis and type 
2 diabetes. We know from previous research that people with psychosis are 2-3 
times more likely to have type 2 diabetes compared to the general population.  
Hearing first hand experiences of living with both conditions is essential in helping 
clinicians and researchers increase their understanding of what it is like living with 
psychosis and type 2 diabetes and to develop strategies to further support people 
to live well.  
People who choose to take part in the study will be interviewed about their 
experiences of living with both conditions and what they understand about their 
psychosis and type 2 diabetes diagnosis. 
4. Why have I been invited to participate?  
We are inviting people to take part who are currently receiving treatment for 
psychosis, and have a diagnosis of type 2 diabetes. We believe you may fit these 
criteria which is why you have been invited to take part.  
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You can take part in this study if: 
• You are over 16 years old 
• You have a diagnosis of psychosis and type 2 diabetes 
5. Do I have to take part? 
 
No, it is up to you to decide whether or not to take part. If you do decide to take 
part, you will be given this information sheet to keep and be asked to sign a consent 
form. If you decide to take part, you are still free to withdraw at any time without 
having to give a reason.  
Your decision whether to take part or not to take part, or to take part and withdraw 
at a later stage, will not affect your routine treatment, your relationship with those 
providing your treatment or your relationship with staff in NHS Ayrshire & Arran.  
 
6. What will happen to me if I take part? 
 
If you decide to take part, Kirsty will give you more information about the study and 
answer any questions you may have. If you would still like to take part, she will 
arrange an appointment time with you. The appointments will take place in a clinic 
room in the community centre, or it may be possible to conduct the interview in your 
home. 
 
Before you begin the interview, you will be asked to sign a consent form to say you 
agree to take part in the study. 
 
Your interview will last around one hour and will be an informal discussion about 
your psychosis and type 2 diabetes.  
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The interviews will be audio recorded to make sure that what is written down in the 
study matches what participants have said. The digital recorder used for recordings 
will be encrypted to NHS standards. All recordings will be transcribed anonymously 
and saved on an encrypted University computer. None of your personal or 
identifiable information will be saved on University computers. Any information that 
may identify you, or anyone else you talk about, will be anonymised. Some quotes 
from your interview may be included in the research paper, but all identifiable 
information will be anonymised.  
 
After you have taken part in the interview, Kirsty will send you a letter thanking you 
for your participation and summarising the main points from your own interview. 
You will be able to contact Kirsty if there is anything in the letter that you do not 
agree with.  
Kirsty may follow up the interview with a telephone call to check-in with you, if this 
is felt appropriate. 
 
Approximately 8-12 people will be invited to take part in the study. The study will be 
carried out in Ayrshire & Arran. 
7. What are the possible disadvantages and risks of taking part? 
 
It is possible that talking about your experiences of your mental and physical 
health condition, and the care you receive for these, may impact your 
psychological wellbeing. If you become upset or distressed as a result of your 
participation in the research, the researcher will be able to help you access 
support from your Community Mental Health Team or other services provided by 
NHS Ayrshire & Arran. You can also suspend your interview, or end your 
participation in the research at any time.  
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8. What are the possible benefits of taking part? 
Although we cannot guarantee that you will find any benefits from taking part in the 
research, you may find it a positive experience helping us develop a better 
understanding of what it is like to live with a long term mental and physical health 
condition.   
9. Will my taking part in this study be kept confidential? 
 
We will inform your GP, Psychiatrist and Keyworker that you are participating in 
the study and any contact you have with the research team will be recorded in 
your clinical notes that are available to your wider care team. This means that the 
researcher will have access to your clinical notes during your participation in the 
research study. 
 
All information which is collected about you, or responses that you provide, during 
the course of the research will be kept strictly confidential. You will be identified by 
an ID number, and any information about you will have your name and address 
removed so that you cannot be recognised from it.  
 
However, please note that should you disclose information concerning risk of 
harm to yourself or other persons, the researcher may need to inform staff 
members involved in your care. The researcher would always discuss this with 
you in the first instance and support you in conveying such sensitive information 
to others.  
 
All data in electronic format will be stored on a secure password–protected 
University computer. No one outside of the research team or appropriate 
governance staff will be able to find out your name, or any other information which 
could identify you.  
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Your information will only be used for the purpose of this research project, and it 
will only be disclosed with your permission, except as required by law. 
 
 
What if I withdraw from this research project? 
 
You can withdraw from the study at any time. You do not have to provide a reason 
and if you withdraw you will continue to receive your usual care and treatment.  
If you do withdraw from the study, any personally identifiable information about you 
will be destroyed. However, annonymised data already collected will be retained to 
ensure that the results of the research project can be measured properly and to 
comply with law. You should be aware that data collected by the research team up 
to the time that you withdraw will form part of the research project results. If you do 
not want them to do this, you should choose not to participate in this study.  
10. What will happen to my data?  
We may be collecting and storing information from you in order to undertake this 
study. Research data will be securely encrypted and retained on a university 
computer on a restricted access network which adhere to General Data Protection 
Guidelines (GDPR). Any identifiable information will be stored in a locked filing 
cabinet held by the data custodian within the University of Glasgow. The 
University is responsible for looking after your information and using it properly. 
Personalised information will be destroyed at the end of the research project but 
other research data will be kept for ten years. Your data will not be passed on to a 
3rd party. 
Researchers from the University of Glasgow collect, store and process all 
personal information in accordance with the General Data Protection Regulation 
(2018). 
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We plan to publish the research in a scientific journal and may present the 
findings to others; however, you will not be identifiable.  
During the course of the study, your data may be examined by a representative of 
the study sponsor, University of Glasgow, to ensure that the study has been 
conducted to proper standards.  
11. What will happen to the results of the research study? 
 
It is anticipated that results of this research project will be published and/or 
presented to others. If this is the case, information will be provided in such a way 
that you cannot be identified. We will use quotes taking directly from individual 
interviews; however, you will not be identifiable based on these quotations and all 
information will be anonymised.  
 
If you feel you would like to receive a copy of the findings, then please let Kirsty 
know and she would be happy to send you a copy.  
 
12. Who is organising and funding the research? 
The research is being sponsored by the University of Glasgow. The study is being 
carried out as part of the requirements of the Doctorate in Clinical Psychology 
training course at the University of Glasgow. 
Investigators for the study are: 
1. Ms Kirsty McPhilemy (email: 2356259m@student.gla.ac.uk) 
2. Professor Andrew Gumley (email: Andrew.Gumley@glasgow.ac.uk; tel: 0141-
211-3939) 
No financial benefits are expected to arise from the conduct of the research.  
  95 
 
 - 95 - 
13. Who has reviewed the study? 
 
The project has been approved by the NHS West of Scotland ethics committee.  
14. Contact for Further Information 
If you wish further information on the study then please contact Kirsty McPhilemy, 
Mental Health and Wellbeing, Gartnavel Royal Hospital, 1st Floor, Admin Building, 
University of Glasgow, Glasgow G12 0XH or on by e-mail: 
2356259m@student.gla.ac.uk. 
15.  What will happen if I want to make a complaint? 
If you have any concerns about the study or the way it is conducted or if you want 
to complain about any aspect of this study, please contact Kirsty McPhilemy in the 
first instance (email: 2356259m@student.gla.ac.uk). 
 
The normal NHS Ayrshire & Arran complaint mechanisms are also available to you 
at https://www.nhsaaa.net/about-us/feedback-and-complaints/ 
 
 
 
Thank you for reading this Participation Information Sheet 
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Appendix 2.7 EXPAND Participant Information Sheet 
 
 
       
 
 
Identification Number: 
 
Name of Researcher: Kirsty McPhilemy 
  
CONSENT FORM Please 
initial 
box 
I confirm that I have read and understood the Participant Information 
Sheet version 2.0 dated 24th January 2020.  
I have had the opportunity to think about the information and ask 
questions, and understand the answers I have been given.   
I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason and without my legal 
rights being affected. 
 
I confirm that I agree to the way my data will be collected and processed 
and that data will be stored for up to ten years in University archiving 
facilities in accordance with relevant Data Protection policies and 
regulations.  
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I understand that all data and information I provide will be kept 
confidential and will be seen only by study researchers and regulators 
whose job it is to check the work of researchers.  
 
I agree that my name, contact details and data described in the 
information sheet will be kept for the purposes of this research project.  
I understand that if I withdraw from the study, my data collected up to that 
point will be retained and used for the remainder of the study.  
 
I agree to my interview being audio-recorded.  
I understand that the recorded interview will be transcribed word by word and the 
transcription stored for up to ten years in University archiving facilities in 
accordance with Data Protection policies and regulations. 
 
I understand that my information and things that I say in an interview may be 
quoted in reports and articles that are published about the study, but my name or 
anything else that could tell people who I am will not be revealed. 
I agree that the researcher can follow up after the interview via a telephone call if 
the content of the interview causes any distress.   
 
I agree that researchers can tell my GP, Psychiatrist and Keyworker that I am 
taking part in this study.  
I understand that any contact with the research team will be recorded by 
the researcher in my clinical notes that are made available to my wider 
care team. 
 
I agree that should significant concerns regarding my mental or physical 
health arise during my participation in the study that a member of an 
appropriate clinical team will be immediately informed.  
 
I agree to take part in the research study.   
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Name of participant Date Signature 
 
 
 
   
Researcher Date Signature 
(1 copy for participant; 1 copy for researcher) 
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Major Research Project Proposal 
 
Name: Kirsty McPhilemy 
 
Matriculation Number: 2356259m 
 
Academic Supervisor:  Prof Andrew Gumley 
Field Supervisor:  Dr Everett Julyan  
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Version Number: 1.0 
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Maximum Word Count: 3,000 
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Abstract 
 
Background: People with serious mental illness have a reduced life expectancy of 15-20 
years. This health inequality is striking, and largely attributable to physical illness. Type 2 
diabetes is seen as one of the most pressing health inequality facing those with schizophrenia, 
2-3 times more prevalent compared to that of the general population. Despite growing 
research into the complex relationship between schizophrenia and type 2 diabetes, less is 
known about how people experience life with both conditions. The limited qualitative 
research available has a focus on staff perceptions of supporting individuals with co-morbid 
schizophrenia and type 2 diabetes. There appears to be even less attempts to understand this 
phenomena using first hand accounts.  
 
Aims: The study aims to explore how people with schizophrenia experience and manage 
their type 2 diabetes.  
 
Methods: Interpretative phenomenological analysis (IPA) will be used to guide the design 
of the study, including data collection and subsequent analysis.  
 
Applications: Results and key findings will be shared with participants, their care teams and 
key stakeholders. It is hoped this will help influence management and care of type 2 diabetes 
leading to better health outcomes for those with schizophrenia.  
 
Introduction 
It has been well documented that people with diagnosed schizophrenia experience poor 
health outcomes and high mortality rates with a reduced life span of 15-20 years compared 
to the general population (Tiihonen et al., 2009). This inequality is largely attributable to 
physical illness such as metabolic and cardiovascular disease, rather than factors associated 
directly to psychiatric illness, such as suicide (Disability Rights Commission, 2006). Co-
morbidity of schizophrenia and type 2 diabetes (T2D) has been widely recognised as one of 
the more pressing health inequalities faced by individuals with schizophrenia, affecting 15-
18% of the schizophrenia population, 2-3 times higher than that of the general population 
(De Hert et al., 2009).  
 Mental and physical health disorders often share a wide range of genetic, social and 
lifestyle related risk factors and thus the relationship between schizophrenia and T2D is 
complex. In the general population, risk factors associated with diabetes include obesity 
(Espeland, 2007), smoking, poor diet, sedentary behaviour (Liu et al., 2013), and poor sleep 
  104 
 
 - 104 - 
(Cappucio et al.,2010). These risk factors are widely accepted to be present amongst people 
with schizophrenia, for example, with rates of smoking in schizophrenia to be estimated at 
70% compared with 20% in the general population (Myles et al 2012). People with 
schizophrenia and other serious mental illness are amongst the most socially excluded from 
our society and routinely experience adverse social determinants of health including poor 
housing, social exclusion, low socio-economic status and unemployment. People with 
schizophrenia face further challenges with regards to equity of healthcare with evidence 
suggesting that diabetic patients with co-morbid serious mental illness are less likely to 
receive adequate standards of diabetic care (Frayne, 2005), with frequent diagnostic 
overshadowing being cited as an area of concern (RC PSYCH, 2010, Smith et al., 2013).  
Historically, anti-psychotic medication has been the main treatment for people with 
schizophrenia and it poses a unique risk factor for T2D. Current research reports that second 
generation antipsychotics such as Clozapine and Olanzapine show notable benefits 
compared to their earlier counterparts; however, their use has been associated with 
abnormalities in glucose metabolism and dramatic weight gain is evident, which in some 
cases has led to fatal diabetic ketoacidosis (American Diabetes Association, 2004). It has 
also been suggested that the chronic hyper secretion of adrenalin; a diabetogenic hormone, 
which is released as a consequence of psychological stress associated with psychosis, makes 
schizophrenia itself an independent risk factor for developing type 2 diabetes (Thakore, 
2004). 
 The risk of T2D posed to those with schizophrenia has been well documented and in 
2015, the National Institute for Health Care and Excellence (NICE) published quality 
standards recommending adults with schizophrenia or psychosis should have regular and 
comprehensive physical health assessments with physical health interventions if necessary 
(NICE QS, 80, 2015). However, there is insufficient evidence to say how such interventions 
should be commissioned (National Collaborating Centre for Mental Health, 2014). Some 
research has suggested that efforts to improve outcomes have been hampered by negative 
staff attitudes and report that many mental health practitioners have limited training in 
physical care and that the monitoring of physical health by community mental health staff is 
generally unsatisfactory (Gournay 1996). Furthermore, mental health nurse training in the 
UK has historically been criticized for failing to deliver on physical health competencies 
(Department of Health, 2006). A literature review by Hultosjo & Hjelm (2010) looked at the 
evidence regarding the care requirements for individuals with psychotic disorders and at risk 
of, or with existing type 2 diabetes, and expressed the important role of mental health nurses 
and paid care workers in motivating diabetic care to help overcome impeding factors of 
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chronic mental illness such as apathy and avolition, which can have a detrimental effect in 
diabetic self-care. People with serious mental illness are often in frequent contact with 
primary care services although this does not necessarily mean the receive good physical 
health care. Improving the physical health of people with schizophrenia depends on holistic 
care from both mental and physical health staff who are aware of the problem and have a 
willingness to think of proactive approaches which will benefit the service user.  
There appears to be a growing literature looking at lifestyle interventions to improve 
physical health outcomes in people with serious mental illness; however, these have been 
criticised due to high drop out rates (Vancampfort et al., 2012) and poor methodological 
quality (Rosenbaum, 2014). A recent Randomized Control Trial (RCT) by Holt and 
colleagues (2018) used a theory based, group structured education programme to target 
obesity in people with schizophrenia and psychosis and found it was neither clinically nor 
cost effective; however, participants were successfully recruited and retained, perhaps 
suggesting a clear interest in such interventions. Two other UK lifestyle intervention trials 
have also been unable to meet their primary outcome of reducing substance use in those with 
schizophrenia (Heslin et al 2017) and reducing cholesterol and cardiovascular risk in people 
with serious mental illness (Osborn et al., 2018). Intervention studies have therefore been 
inconclusive in their efforts to improve the physical health of people with serious mental 
illness.      
Despite the growing research exploring the potential causes and epidemiology of 
T2D in schizophrenia and reported attempts to manage physical health with lifestyle 
interventions, less is known about how people with schizophrenia experience their physical 
health. How do people cope with co-morbid conditions manage their self-care and what are 
their health beliefs? El-Mallakh (2006) interviewed 11 respondents with comorbid 
schizophrenia and diabetes and reported psychiatric symptoms as major barrier to their 
diabetic self-care; however, noted that some were able to apply their acquired knowledge of 
managing their mental health onto their physical health condition as a useful strategy. 
Adherence to diabetic self-care can be difficult, requiring challenging life style changes for 
even those who possess high level of self-discipline (Fisher et al., 1997) and symptoms 
commonly experienced with schizophrenia, such as avolition and apathy, may pose a barrier 
to diabetic self-care. Of the limited qualitative research in the area, much has focussed on 
care staffs’ perceptions in supporting service users to manage their conditions (Hultsjo & 
Hjelm, 2012, McBain et al., 2016) with very little research looking at the first-hand accounts 
of people living with comorbid schizophrenia and type 2 diabetes. The purpose of the present 
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study therefore is to fill a gap in the current literature and provide an insight into the 
experience of living with co-morbid schizophrenia and type 2 diabetes. 
 
Aims 
 
The aim of the current study is to explore how people with schizophrenia experience and 
manage their type 2 diabetes by using first-hand accounts.  
 
Plan of Investigation 
Method 
Interpretative phenomenological analysis (IPA) (Smith, Flowers & Larkin, 2009) will be 
used to guide the design of the study, including data collection and subsequent analysis. This 
methodology has been chosen to allow the researcher to engage with participants’ 
experiences of co-morbid chronic illness and attempt to make sense of their world through 
rigorous interpretation. IPA has an experiential focus, which places the participant as the 
expert of their own experiences and the idiographic level of analysis implies a focus on the 
particular, rather than the general. With its roots in phenomenology, it is interested in how 
people perceive and understand major life events. Double hermeneutics also plays an 
important role in the IPA process in that as the participant attempts to make sense of their 
world, the researcher must also attempt to critically capture and make sense of how the 
participant has arrived at their interpretation; by finding the ‘insider’s perspective’ (Conrad, 
1987). 
 
Reflexivity  
Husserl argued that human beings are sense-makers, constantly seeking to attach meaning 
to phenomena. Therefore, the researcher’s own interpretation of data may be contextualised 
by their prior experiences and learning. For this reason, it is important to highlight that the 
researcher has a specific interest in the area of health psychology and the different health 
psychology models for understanding thoughts and behaviour related to physical health. In 
order to manage pre-conceptions and assumptions which may arise from this, the researcher 
will engage in the process of reflexivity by critically evaluating how fore-conceptions may 
influence the research (Finlay, 2009). It is hoped that this will help to avoid the researcher 
imposing their own ideas onto the participants.  
 
Participants 
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Although often thought to benefit from using fewer participants (Smith et al., 1999;2007), 
there seems to be no right answer to the question of sample size in IPA research. There may 
be an argument for smaller samples being preferential in IPA given its commitment to 
idiography which seeks to understand the meaning of unique and often subjective 
phenomena. This is in contrast to the mainstream nomethic approach in psychology which 
often prefers large sample sizes and concerns itself with the rules that govern the general 
population, often explaining objective phenomena. Arguably, detailed interpretative 
accounts may be sacrificed in larger samples, as meaningful idiosyncrasies and unique 
experiences may become overlooked, running the risk of generalisation amongst participants 
(Smith et al., 2007). With this in mind, the study hopes to recruit a homogenous sample of 
8-12 participants. Inclusion criteria will include: i) a clinical diagnosis of schizophrenia or 
schizo-affective disorder, and co-morbid type 2 diabetes and ii) participants over 16 years 
old. Exclusion criteria will include: i) those with affective psychosis ii) those under the 
Adults with Incapacity (Scotland) Act (2000) and ii) those who are unable to understand the 
study’s aims and procedures. This is to ensure participants can engage well throughout the 
interview process and to optimise the likelihood of quality responses.  
 
Recruitment 
The researcher will approach mental health teams across NHS Ayrshire & Arran and third 
sector organisations including; Ayr Action for Mental Health (AAMH) in South Ayrshire 
and SAMH ALBA (Active Living Becomes Achievable) in North Ayrshire to help identify 
potential participants for recruitment. Additionally, the researcher will approach some 
General Practices in NHS Aryshire and Arran and ask for their help to identify potential 
participants using data from their practice computer systems.  
 
Collecting Data 
Semi-structured, in-depth interviews will be used to explore the experiences of people with 
co-morbid psychosis and type 2 diabetes. A topic guide (appendix A) will loosely guide the 
researcher and will allow flexibility to probe further into interesting responses from the 
participant or into an area not covered by the interview questions. Interviews will then be 
analysed using IPA with the aim of exploring the meanings which participants assign to their 
experiences.  
 
Design 
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A short leaflet describing the study will be designed to be left in waiting rooms and given to 
staff to pass on to potential participants. If service users express an interest in participating 
in the study, they will be sent a patient information leaflet with further details and given at 
least 24 hours to consider taking part. The location of interviews will depend on where the 
patient feels most comfortable; either in their own homes or clinic room and therefore this 
will be arranged with the participant on an individual basis. A digital recorder encrypted to 
NHS standards will be used to record each interview. It will be anticipated that interviews 
will last up to one hour and participants will be able to take a break at any time. Recorded 
interviews will then be uploaded to an encrypted computer folder and analysed as detailed 
below. Recordings will be deleted one year after completion of the research project. 
 
Analyses 
The first stage of the analysis will be to listen back to the recordings to form verbatim 
transcripts. These will be read and re-read in order for the researcher to immerse themselves 
in the participant’s world. This process will play an important role in locating richer and 
detailed sections of the participant’s narrative as well as identifying any paradoxes and 
subsequently helping to form a model of each participant’s experience.  
The next stage will be the initial coding of the data and will involve making exploratory 
comments based on the original transcripts. Exploratory comments will be divided into 
descriptive, linguistic and conceptual comments. This coding process will lead to the 
development of emerging themes. These emerging themes will be clustered for each 
individual transcript. Recurrent themes will be noted using a theme table and those themes 
which occur most frequently, whilst depicting compelling and interesting portrayals of 
experience, will be chosen to be represented in the research paper.   
 
Ethical Issues 
Voluntary and informed consent will be sought, and participants will be able to withdraw 
from the study at any point without this having any impact on them. Participant anonymity 
will be respected throughout the research process and pseudonyms will be used in the write 
up to prevent identification of those taking part. The researcher will use the ‘find and replace’ 
function on Microsoft Word to change any names of individuals or places which may 
identify participants. The researcher will also make clear limitations of confidentiality to 
participants at the beginning of the research process and remind them of this throughout if 
necessary. Additionally, the researcher will also write a letter to the person responsible for 
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the participants care (e.g. psychiatrist, GP) to inform them of the individual’s participation 
in the study.  
The consent form and information leaflet will be made jargon free and easy to read. 
Participants will be encouraged to ask questions to allow ample opportunity to understand 
the research aims and procedures. In order to adhere to Good Clinical Practice (GCP) the 
researcher will check that each participant fully understands the patient information leaflet. 
If the participant has not read the patient information leaflet, then they will have time to do 
so and then given at leas 24 hours to consider their participation. The study will be sponsored 
jointly by the University of Glasgow and NHS Ayrshire and Arran. Approval will be sought 
by the Clinical Governance Department, NHS Ayrshire and Arran and Caldicott Guardian 
approval will be obtained.  
 
Health and Safety Issues 
The researcher may be required to visit participants in their homes to conduct interviews and 
will therefore follow local NHS procedures for lone working. Each home visit will be risk 
assessed beforehand by the researcher. 
 
Financial Issues 
The researcher may claim for travel expenses if interviews take place in the participants’ 
homes.  
 
Timetable 
Proposal draft   November 2018 
Proposal final   January 2019 
Ethics Application  Jun 2019 
Data Collection Sept 2019 – Apr 2020 
Data analysis and write up     May-Jul 2020 
Submission of MRP  31st July 2020 
Viva   3-4th Sept 2020 
 
Practical Applications 
 
It is hoped that those with co-morbid schizophrenia and type 2 diabetes, and those involved 
in their care, will benefit from the research study via dissemination of results and learning 
from the study. Those who participated in the study will be offered a copy of the executive 
summary, or a copy of the completed research project if this is requested. Results will also 
be disseminated to the mental health teams and GP practices who were involved in the 
recruitment of participants. It is hoped that this may help improve outcomes of those with 
co-morbid schizophrenia and type 2 diabetes by increasing an understanding of what it may 
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be like to live with both conditions. Additionally, publication of the research in a peer-
reviewed journal (e.g. The Journal of Health Psychology) will help to share knowledge on a 
wider platform to help effect change by promoting an understanding of living with comorbid 
chronic physical and mental health conditions both at an individual and institutional level.  
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